The cheapest GLP-1, priced over a year

The shortlist pick: one flat price that doesn't climb as your dose does, both molecules on a single plan, and a nationwide async intake you can finish on a break.

Semaglutide:

$99/mo

Pricing:

Flat

First dose:

Same week

Compounded semaglutide at $69 a month and tirzepatide at $119, one flat price that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. Both figures are advertised against struck-through list prices of $299 and $399 under a live countdown clock, and the promise to lock that rate for life is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.

Semaglutide:

$69/mo (was $299)

Pricing:

Flat

First dose:

Days

The lowest advertised flat rate on this roster — $79/mo semaglutide, $129/mo tirzepatide, fully async — but no stated time-to-first-dose, and the price rides on a 'locked forever' promo that real Trustpilot reviews say hasn't always held.

Semaglutide:

$79/mo

Pricing:

Flat

First dose:

Not disclosed

Both prices came down since our last check: read live on 2026-08-26 the catalog reads from $79 a month for compounded semaglutide and from $159 for tirzepatide, against $99 and $169 in July. Same price at every dose is stated beside them, so titrating up does not raise the bill — but from is a floor and no ceiling or dose ladder is published anywhere. One question this record used to leave open is now answered on the site itself: yourEra says its clinician network is licensed in all 50 states, and repeats it in a badge and in its own founding story. The single price covers the telehealth visit, the medication, injection supplies, dose adjustments, unlimited messaging and shipping. Two things belong on your list before you pay. The refund policy stops refunds the moment the pharmacy begins preparing your order, whether or not it has shipped. And the Terms require you to have a device with a working video camera, which is the closest the site comes to telling you whether a live visit is part of this.

Semaglutide:

From $79/mo

Pricing:

Same price at every dose, quoted as a floor

First dose:

Not published

A flat $88/mo semaglutide and $157/mo tirzepatide with named medical groups and pharmacies behind it — the cheapest sticker in this batch, but a video visit is required and cancellation is by email, not a dashboard toggle.

Semaglutide:

$88/mo

Pricing:

Flat

First dose:

After a required video visit

A fast, fully async start with a needle-free sublingual tirzepatide option and — a genuine upgrade since our last check — flat pricing stated in writing. The catch is a state list it still won't publish.

Semaglutide:

$99/mo (flat)

Pricing:

Flat

First dose:

Days

$99/mo semaglutide, $183/mo tirzepatide, all 50 states, a named physician personally reviewing every intake, and a real 5-7 day timeline — on a broader peptide platform where GLP-1 pricing is genuinely invisible unless you know to pull the page's own data bundle.

Semaglutide:

$99/mo

Pricing:

Flat

First dose:

5-7 days total (24-48hr provider review)

Async-first compounded GLP-1 with a rarity for this list — free health coaching — at a flat one-price-all-doses rate. Fast and friendly up front; the strict, non-refundable fine print is the trade-off.

Semaglutide:

$119/mo

Pricing:

Flat

First dose:

Days

Compounded semaglutide from $129 a month and tirzepatide from $199, held at the same price at every dose, plus a separate microdose line from $109 for anyone who wants a gentler metabolic effect rather than maximum weight loss. Lttl covers all 50 states and Washington D.C., says it prescribes and ships within 48 hours, and attributes compounding to U.S.A.-licensed pharmacies it does not name. The catalog runs well past weight loss into NAD+, sermorelin, glutathione and B12 from $79, so read the longevity menu as a separate business from the GLP-1 you came for. Prices are published as starting points rather than a single rate, and the first-order discount of up to $140 is promotional.

Semaglutide:

From $129/mo (floor)

Pricing:

Flat

First dose:

Days

$147/mo semaglutide, $249/mo tirzepatide, an oral tablet option, brand-name Wegovy/Zepbound on the same menu, and 49-state coverage — the best state reach here, undercut by a cancellation policy that isn't published anywhere.

Semaglutide:

$147/mo

Pricing:

Flat

First dose:

Not stated

The async, needle-optional value play: oral or injectable semaglutide and tirzepatide from a low starting price, no video visit, ~3 days to a script — listed with its February 2026 FDA warning letter in plain view.

Semaglutide:

$149/mo (injectable) · $99/mo (oral lozenge)

Pricing:

Scales with dose

First dose:

Days

Real pre-intake pricing — $249/mo tirzepatide, $149/mo semaglutide-B12 bundle — on a broader TRT-focused platform whose own pages contradict each other on FDA approval, and whose cancellation policy (email only, 48-hour lockout, all sales final) is the strictest in this comparison.

Semaglutide:

$149/mo

Pricing:

Tiered

First dose:

Not stated

The price-first partner: some of the lowest flat, all-inclusive compounded pricing we track, nationwide and async — strong if the monthly number is your deciding factor and you read the annual-prepay fine print.

Semaglutide:

$175/mo

Pricing:

Flat

First dose:

Days

Bodybuilding Health+ does the disclosure part better than most of this market and the branding part more loosely. It names four compounding pharmacies outright with phone numbers, and it names two lead physicians with their NPI numbers — both of whom check out as active MDs in the federal registry. Pricing is flat at every dose and public before any intake: $179 a month for compounded semaglutide and $209 for tirzepatide, dropping to $139 and $159 only if you buy a year up front. The looser part is the name. The operator is Dynamo Group LLC of Boca Raton, not Bodybuilding.com, and the 'trusted by millions since 1999' line on the page is the licensor's heritage rather than the clinic's. It's compounded-only, so there's no FDA-approved Wegovy or Zepbound route, the bundle discounts come with no published refund terms, and a prominent '4.8 (200+ reviews)' badge sits above a Trustpilot widget I couldn't verify because Trustpilot blocks automated checks.

Semaglutide:

$179/mo

Pricing:

Flat

First dose:

Async intake, no published turnaround

Unusually complete disclosure for a compounded seller: four dispensing pharmacies named outright with links and phone numbers, OpenLoop named as the prescribing partner, and genuine brand access to Wegovy, Zepbound and Ozempic alongside the compounded line. Compounded GLP-1 injections start at $179 a month and daily dissolvable tablets at $249. The price follows the form, not the molecule — the product page never names semaglutide or tirzepatide, and the terms confirm both are in scope, so either molecule costs the same. Two caveats matter for planning. The brand products are quoted as a membership plus a medication cost that is never published, and the membership appears at two different figures on one page: $99 beside Zepbound and Wegovy, $171 beside Ozempic. And the terms provide that a provider may switch your molecule, with continued enrollment counted as consent and charges continuing. It also discloses that people in its advertising may be actors or artificial intelligence rather than clinicians. No time to first dose is published.

Semaglutide:

From $179/mo (floor)

Pricing:

Priced by form, not by molecule; brand sold as membership plus an undisclosed medication cost

First dose:

Not published

Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.

Semaglutide:

$199/mo

Pricing:

Flat

First dose:

Async in 43 states

The widest menu on this list — injections, lozenges, drops and a brand-name lane — with a flat price that genuinely holds as your dose climbs. The catch is the exit: every plan locks you in for two months.

Semaglutide:

$199/mo

Pricing:

Flat

First dose:

About a week

Both molecules now have confirmed, tiered pricing — $199-249/mo semaglutide, $299-356/mo tirzepatide, depending on plan length — found by walking the actual intake, since the public pages still carry no price at all.

Semaglutide:

$199/mo month-to-month ($185/mo on the 12-month plan)

Pricing:

Tiered by plan length

First dose:

About a week

The one brand in this cluster that prints its prices: seven weight-loss products, compounded and brand, each with a public number. What it will not tell you is when anything arrives, or how you would ever stop.

Semaglutide:

$199/mo

Pricing:

Posted per product

First dose:

Not disclosed

Semaglutide is $199 a month as either the weekly injection or a daily pill, tirzepatide is $299 bundled with B12 and glycine, and the number does not move as your dose goes up — which is the whole point if you are budgeting a year ahead rather than a month. Every plan includes a smart scale that separates fat from muscle. Two things to read before you spend the twenty minutes: no price appears anywhere on the public site until the quiz has your height, weight and date of birth, and the money-back banner on the homepage is not the guarantee written into the contract.

Semaglutide:

$199/mo, injection or oral

Pricing:

Flat

First dose:

Next-day delivery once approved (review turnaround not disclosed)

Semaglutide runs $199/mo month-to-month and tirzepatide $299, falling to $99 and $159 only if you prepay a full year. Provider review takes about 24 hours and delivery 2-3 days, both published, and the site names its pharmacies, its clinical group and its chief medical officer. The middle of the ladder is where it gets slippery: the 6-month rates are introductory and renew higher.

Semaglutide:

$199/mo month-to-month, $99/mo on the 12-month plan

Pricing:

Tiered by plan length

First dose:

About 24 hours to provider review, 2-3 days to delivery

A flat $199/mo semaglutide, $299/mo tirzepatide, with an option most of this batch skips: a sublingual tablet instead of a weekly shot, plus no video visit required — but the FDA issued its parent entity, Lean Rx, Inc., a warning letter on 02/20/2026 (ref. 717989) for mislabeling itself as the compounder on its own product images and for marketing language implying its compounded products share FDA-approved status with Mounjaro and Zepbound, which they don't. Confirmed directly on FDA.gov; SkinnyRx's own site never mentions it.

Semaglutide:

$199/mo

Pricing:

Flat

First dose:

Not stated

The cheapest headline of the three and the least you can know before paying for it: BreezeMeds sells a '$199 weight-loss injection' without naming the drug, publishes no terms of any kind, and quotes 2 to 3 weeks to a first dose.

Semaglutide:

Not named on site

Pricing:

Starting price only

First dose:

2–3 weeks

RxSpan MD is a genuinely well-disclosed service wrapped in marketing that undercuts it. The disclosure: four compounding pharmacies named with phone numbers, two lead physicians named with NPI numbers that verify as active MDs, flat pricing posted before any intake, both compounded and real FDA-approved brand GLP-1s on one platform, and oral capsules for anyone who won't inject. Compounded semaglutide is $249 a month and tirzepatide $329, with brand Zepbound at $1,069, Ozempic at $1,299 and Wegovy at $1,349. The marketing is the problem. Its testimonials still name a different company — one patient describes what she 'expected from CareGLP' — and the doctors quoted in them are not the clinicians the same page names as its medical team. The homepage is built around a board-certified plastic surgeon who founded the practice but is licensed in California only and isn't the prescriber. Its compounded prices also sit above the roster median, and the oral capsules cost the same or more than the injections.

Semaglutide:

$249/mo

Pricing:

Flat

First dose:

Often approved on assessment alone

The oversight-forward compounder: labs and a live provider visit bundled into every plan, with a gentle microdosing lane — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.

Semaglutide:

$249/mo with no commitment ($212/mo on the 12-month plan)

Pricing:

Flat per dose; tiered by plan length

First dose:

Days

Try Ageless is built the way a time-poor patient would design it: the entire price list is public before any intake, the assessment is asynchronous with no required video visit, and pricing is flat at every dose so a titration never triggers a surprise bill. Month to month it is $279 for compounded semaglutide and $349 for tirzepatide, both including B12 and all injection supplies; sublingual tirzepatide drops are $199. The catch is the headline — the product cards lead with '$199/mo' and '$249/mo', which are yearly prepays of $2,388 and $2,988 divided by twelve. It names its prescriber (Wasef Health, PC, with Michael Wasef, MD, NPI 1417261926, active internal medicine) and its compounding pharmacy (The Pharmacy Hub LLC, NPI 1316684616, also active), both of which verify in the federal registry — genuinely above average disclosure. But the terms of use publish no cancellation policy, no refund policy and no auto-renew disclosure despite 'cancel anytime' marketing, and no state list exists anywhere on the site.

Semaglutide:

$279/mo

Pricing:

Flat

First dose:

Async review, no published turnaround

Async, fast, and all-inclusive on paper — read live on 26 August 2026 its weight-loss page starts sublingual semaglutide at $249 a month and the injection at $297, with medication, nurse support, shipping and follow-ups bundled into one rate and no membership on top. The intake is a quiz with no appointment, approval is stated in hours and shipping in one business day, which is exactly the shape a working mother wants. Two things sit against that. The page promises "Cancel Anytime" three times over, while its own Terms of Sale say a prescription order generally cannot be canceled more than 24 hours after you place it, that medication already received is not refunded, and that a returned medication carries a $35 disposal fee — the marketing and the contract are not saying the same thing. And it carries an FDA warning letter dated 9 September 2025 over marketing compounded GLP-1s as containing the same active ingredient as the branded drugs. No tirzepatide price is published on any public page any more, no compounding pharmacy is named, and no state list exists — though it does name thirteen executives including its Chief Medical Officer, which is more disclosure than most of this list offers.

Semaglutide:

$297/mo for the injection, all-inclusive

Pricing:

Tiered by format and plan length

First dose:

Approved within hours, ships in 1 business day

The async standout: no video visit, no quiz wall, prices posted in the open, and needle-free tablets alongside the injections — but the headline price is a starting dose, not a flat rate, and only 36 states are in.

Semaglutide:

$299/mo

Pricing:

Scales with dose

First dose:

About a week

The insurance-and-brand specialist: real Wegovy and Zepbound access with the paperwork handled, one flat compounded price for either molecule, and an oral pill — priced by plan, billed every four weeks, and thin on state disclosure.

Semaglutide:

$299/mo

Pricing:

Tiered

First dose:

About a week

Flat pricing that genuinely holds through titration, and a needle-free tablet — undercut by an open FDA warning letter, an F at the BBB, and a checkout that takes your money before a clinician has looked at you.

Semaglutide:

$299/mo

Pricing:

Flat

First dose:

1–2 weeks

For a working mother the appeal here is logistics as much as money: a fully online intake with no video call to schedule, all 50 states, and one flat charge per month that covers the visit, the plan, the medication and shipping — held at the same price whatever dose you end up on. Month to month that is $79 for compounded semaglutide and $109 for compounded tirzepatide; the $69 the homepage headlines under a countdown timer is the twelve-month tier, and $95 is its tirzepatide equivalent. Flat-by-dose is the part that actually protects a budget, because dose-priced providers routinely double between a starting and a maintenance dose. Two things to weigh against that. The off-ramp is narrow: subscriptions auto-renew, canceling means emailing care@leanmeds.com at least 48 hours before the processing date, and the order stops being refundable the moment you submit the medical intake. And the operator named throughout its own Terms — Trinity HealthCare Supply, LLC — is the company FDA wrote to on 8 June 2026 under its other brand, altRx, for labeling compounded vials with its own name when it was not the compounder and for calling compounded GLP-1s 'clinically proven.' That letter concerns altrx.com, not this site, but it is the same legal entity at the same Miami suite, and no pharmacy or clinician is named here either.

Semaglutide:

$79/mo month-to-month ($69/mo on the 12-month plan)

Pricing:

Flat membership, tiered by term

First dose:

Not published

Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter.

Semaglutide:

$79/mo, same price at every dose

Pricing:

Flat

First dose:

Not published

Oral access at parity with injectable pricing for both molecules — genuinely uncommon — at a standing $79/$133 new-patient tier, though the follow-on refill rate isn't published and NuuVim's own state coverage couldn't be confirmed live despite the affiliate directory claiming all 50 states.

Semaglutide:

$79/mo

Pricing:

Tiered

First dose:

Not disclosed

An outlier-low, locked-rate flat price — $83/mo for tirzepatide, $250/mo for semaglutide — stated with no promotional hedge, though notably below every comparable compounded-tirzepatide price elsewhere among the providers we track and worth confirming carefully before signing up.

Semaglutide:

$250/mo

Pricing:

Flat

First dose:

Not published

The cheapest entry on this page — $86 for compounded semaglutide, $125 for tirzepatide — with the results claims printed on the same cards as the prices. "Average 15-20%" on one, "Average 20-25%" on the other. That upper figure is above what tirzepatide achieved at its maximum dose in SURMOUNT-1, and these are compounded products that were not in that trial. Take the prices; discount the percentages.

Semaglutide:

From $86/mo

Pricing:

Flat monthly, lowest on the roster

First dose:

Not published

Do the milligram arithmetic before you budget. $399.99 buys 60 mg of tirzepatide, which is exactly twelve weeks at 2.5, 5 and 7.5 mg — about $145 a month. At a 10 mg maintenance dose the same 60 mg is six weeks, and at the 15 mg ceiling four, so the monthly figure runs from $145 to about $435 depending on where you finish. The clinic publishes every number that makes that computable. It just headlines the lowest one.

Semaglutide:

$87/mo at the starting dose; about $250 at maintenance

Pricing:

Tiered

First dose:

As soon as tomorrow, per the clinic

An all-inclusive $89/mo semaglutide program, LegitScript-certified and licensed in all 50 states — undercut by a homepage that advertises a different $99 first-month figure for the same product, and a tirzepatide option that's listed but never separately priced.

Semaglutide:

$89/mo

Pricing:

Flat

First dose:

Not stated

A LegitScript-certified compounded GLP-1 platform advertising $89/mo semaglutide and $139/mo tirzepatide — but those are first-month-only promos, the real recurring price is never published, and no turnaround time is stated.

Semaglutide:

$89/mo first month (promo)

Pricing:

Not disclosed

First dose:

Not disclosed

Pepti publishes the lowest semaglutide price in this entire roster — $99 a month, flat at every titration dose, with the medication, physician review, shipping, refill management and unlimited messaging with your prescribing doctor all inside it. Tirzepatide is $199 on the same all-in, flat-at-every-dose basis. That number is low enough to deserve skepticism, so it is worth saying exactly where it comes from: Pepti states it on a dedicated cost page, repeats it in its FAQ ('we keep pricing flat and transparent at $99/mo all-in'), and prices the comparison against Hims, Henry Meds and Mochi on the same page. It names two prescribing physicians and says its medication is compounded by FDA-registered 503A or 503B pharmacies, though it never names which. The real limits are reach and format: it ships to 36 states rather than 50, it is cash-pay only and bills no insurance, and its needle-free oral GLP-1/GIP drops cost $349 — well above its own injection.

Semaglutide:

$99/mo

Pricing:

Flat

First dose:

Physician review, async

Flat at every dose - $99 semaglutide, $134 tirzepatide, all fifty states - which makes the annual math trivial. The site never names its operating company.

Semaglutide:

$99/mo

Pricing:

Flat

First dose:

Not published

$99 semaglutide, $149 tirzepatide, flat at every dose, all 50 states. Renewal prices match advertised prices in the checkout data, so the no-price-rise claim holds. A plan month is four weeks; the '12-month' plan at $999 is 48 weeks. Same operator as Lean Meds, altRx and NextMeds — one company, four storefronts — and that operator holds FDA letter 728236, still open.

Semaglutide:

$99 per 4 weeks

Pricing:

Flat, fixed as the dose rises

First dose:

Not published

A named-Medical-Director program licensed in all 50 states, from $99/mo semaglutide and $183/mo tirzepatide, with no membership required — but it carries a 2025 FDA warning letter over how it described its compounded medication, and both prices are 'From' starting prices rather than a guaranteed working-dose rate.

Semaglutide:

From $99/mo

Pricing:

Tiered

First dose:

Not published

A genuinely flat $99/month for either molecule, including consults and shipping per its own FAQ — undercut by a stale $139 figure still live in the page's meta description and a clinical-review team ('Lion MD') it shares with at least one other provider on this roster.

Semaglutide:

$99/mo

Pricing:

Flat

First dose:

Ships 5–7 business days after approval (review turnaround not disclosed)

One of the lowest disclosed GLP-1 starting prices in this round — from $99/mo semaglutide, $133/mo tirzepatide — with an explicit no-membership, no-hidden-fee claim, though the real ongoing rate at a working dose isn't confirmed.

Semaglutide:

Starting at $99/mo

Pricing:

Tiered

First dose:

Not published

Both prices came down since our last check — read live on 2026-08-26 the product cards say compounded semaglutide from $99 a month and tirzepatide from $199, against $149 and $224 in mid-August, with microdose versions at $119 and $139 beside them. Still "from", and Medro is unusually candid about what that means: its own FAQ says starting-at pricing "reflects the lowest typical option" and that final cost varies by medication, dose, supply duration, partner pricing, availability and eligibility, while a footnote under the cards calls the pricing "illustrative". Two other things this record used to get wrong. The site does name its operating entity, Medro Health Technologies, Inc., in the Refund Policy, along with its clinical partner Arora Health & Aesthetics in Seattle and its pharmacy partner The Pharmacy Hub in Miami. And it does publish a cancellation policy — one that sits awkwardly against the FAQ, because the FAQ says there is no membership and nothing recurring to cancel while the Refund Policy describes a subscription charged the moment you finish the intake form, needing 72 hours' notice to stop, with no refund on cancellation.

Semaglutide:

From $99/mo

Pricing:

From-price floor the site itself calls illustrative

First dose:

Same-day visits advertised; shipping window not published

A multi-category telehealth shop with some of the lowest disclosed GLP-1 starting prices in this batch — from $99/mo semaglutide, $140/mo tirzepatide — though the site's own disclosure that pricing 'may vary' means the real ongoing cost isn't fully locked in.

Semaglutide:

From $99/mo

Pricing:

Tiered

First dose:

Not published

One of the network's longer-established telehealth operators (since 2008) — as low as $99/mo semaglutide, $269/mo tirzepatide — though state coverage isn't itemized beyond a 'trusted nationwide' claim.

Semaglutide:

As low as $99/mo

Pricing:

Tiered

First dose:

Not published

One-time 30-day kits — as low as $99 for a single-dose-vial option, or $125-145 for the larger HomeKit — with a fully async physician review and a full refund if not approved, but no stated time-to-first-dose and no state list.

Semaglutide:

$99/mo

Pricing:

Tiered

First dose:

Not disclosed

If you have coverage, this is the one worth pricing out properly. Shapely says it is in network with Medicare and major PPO plans and quotes brand-name co-pays of "typically $25 per month" — a different order of cost from anything else here. The membership arithmetic needs care: $99 a month, $49 for the first, and it explicitly excludes medications and labs. So budget $99 plus $99 for semaglutide, or $99 plus $166 for tirzepatide, on the cash-pay route.

Semaglutide:

$99/mo cash-pay, on top of the membership

Pricing:

Membership plus medication, insurance accepted

First dose:

Not published

An established Minnesota weight-management company rather than a new domain: Livea Medical, PLLC under Minnesota Weight Control, Inc. Compounded semaglutide from $99 a month, tirzepatide from $199 "when available" — the supply caveat is theirs, and it is worth having in writing. The price lives inside a collapsed FAQ rather than a pricing page, which is where it is most likely to go stale unnoticed.

Semaglutide:

From $99/mo

Pricing:

Flat monthly, tirzepatide subject to availability

First dose:

Not published

One of only two sellers on this roster that publishes the states it serves, and the only one that also runs in-person clinics. Twenty-six states, enumerated by name, which is a materially stronger claim than the all-fifty assertion most of this market makes. Semaglutide with B12 starts at $99 a month and tirzepatide at $179, on monthly or quarterly plans, and both are floors rather than rates — the per-dose ladder appears only after the intake takes a name and an email, so the maintenance cost is exactly what the public pages withhold. Labs are billed on top at $89 or $189, disclosed in the FAQ rather than beside the price. The operating company, Magnolia Regenerative Medicine Health, LLC, is named with a working phone number. The exit is the tight part: no refunds on medications, and cancellation requires written notice at least 24 hours before renewal. No time to first dose is published.

Semaglutide:

From $99/mo (floor)

Pricing:

From-price floor; the dose ladder appears only after an identity gate

First dose:

Not published

A three-molecule menu — semaglutide, tirzepatide, and the less commonly offered liraglutide at $150/mo — starting at $99/mo with 'all doses included' pricing and HSA/FSA accepted, though the homepage's combined banner and its separate tirzepatide listing don't clearly say which price is for which drug.

Semaglutide:

$99/mo

Pricing:

Tiered

First dose:

Not disclosed

Compounded semaglutide from $99 a month and tirzepatide from $149, with no membership fee, a dietitian attached to every plan, and a genuinely deep FAQ library that has a whole section on pregnancy — rarer here than it should be. Read two promises carefully before you sign. Every page says 'No price increases — ever', while the billing consent you actually click to accept reserves Harbor's right to change pricing on thirty days' notice. And 'No results? No charge' is a twelve-month guarantee with eight conditions attached, including staying enrolled for all twelve months and taking no other weight-loss medication in the year before you start. Every price on the site is a floor, so what you pay after the first month is not published anywhere.

Semaglutide:

From $99/mo — a floor; no ongoing rate is published

Pricing:

Not disclosed

First dose:

Not published

FDA warning letter #721472 (Feb. 2026), which names newself.com. A flat, dose-independent price for both molecules — $99.97/mo semaglutide, $144.49/mo tirzepatide, same price at every dose — nationwide, though it requires 3 months upfront.

Semaglutide:

$99.97/mo

Pricing:

Flat

First dose:

As little as 4 days

A flat 'For As Low As $25/Week' (about $100/mo) plan for either molecule, built around a named 503B pharmacy partner and included dietitian coaching — genuinely distinctive disclosure for the price, but it never says which states it reaches.

Semaglutide:

$100/mo

Pricing:

Flat

First dose:

After doctor-guided selection (timeline not disclosed)

Semaglutide with B-6 from $109 a month, tirzepatide with B-6 from $159 — both clearly labeled on the weight-loss page, which is more than several competitors manage. The card between them, Bio-Boost Plus at $129, is a lipotropic fat-metabolism injection and not a GLP-1, and its position makes it easy to misread as one. The structural detail that matters for a working schedule: provider contact here is quarterly, not monthly, so the titration weeks run largely unattended.

Semaglutide:

From $109/mo with B-6

Pricing:

Flat "from" price inside a membership, billed monthly or annually

First dose:

Not published

$114 is the lowest semaglutide figure on this page, and it comes with a condition SurpassMD prints only in its FAQ: the price applies "for eligible patients with a promotion". The standing rate is published nowhere, which makes budgeting past the first cycle guesswork. What is solid: all fifty states plus DC, 503A compounding, cold-chain shipping within 48 hours of approval, HSA and FSA accepted, cancel anytime. There is an oral semaglutide as well, with no price attached.

Semaglutide:

As low as $114/mo, promotional

Pricing:

Promotional pricing only; no standing rate published

First dose:

Ships within 48 hours of approval

$114.99 a month is $1,379.88 a year for semaglutide, and $191.99 is $2,303.88 for tirzepatide — both all-inclusive, which is a good deal by this page's standards. The problem is establishing them at all. The table those figures live in is headed "Transparent Monthly Pricing" and renders $0.00 without JavaScript; the one real number in the served HTML is $195.82, which the page never displays.

Semaglutide:

$114.99/mo

Pricing:

Flat

First dose:

Days — expedited cold shipping included

Mondae is built for someone who wants the decisions made up front and then left alone. Price, plan length and — unusually — which of six named compounding pharmacies fills the prescription are all settled before intake, the questionnaire is asynchronous with no video call to book, and it serves all 50 states. The rate is $115 a month for compounded semaglutide and $145 for compounded tirzepatide, with no membership fee stacked on top and no increase as you titrate: 'your dose may increase, but your price is fixed.' For a working parent that predictability is the whole point, because a dose-priced plan can quietly double between a starting and a maintenance dose. The pharmacy disclosure is the standout — Boudreaux, Rush, Hallandale, Greenwich, Align and VialsRx, named and selectable, where most of this category names none — with the honest caveat that Mondae itself flags: each ships to different states and formulations 'may contain additional additives.' Both prices were verified from a rendered page rather than a marketing card, because the raw HTML ships a '$NNN' placeholder, and they agree with the homepage card and the page's own structured data. What is absent is routine: no named clinician behind the contracted Bask Telehealth network, no labs, no refunds once medication is dispensed, and nothing addressing postpartum recovery, breastfeeding or PCOS.

Semaglutide:

$115/mo (flat at every dose)

Pricing:

Flat, fixed as the dose rises

First dose:

Not published — ships after provider review

FDA warning letter #721479 (Feb. 2026), which names joinbliv.com. An explicitly no-video-visit, fully async intake — as low as $116/mo semaglutide, $199/mo tirzepatide — with CareCredit and Klarna pay-later options, though state coverage isn't published.

Semaglutide:

As low as $116/mo

Pricing:

Tiered

First dose:

Not published

No video visit and no membership fee — semaglutide from $117.96/mo, tirzepatide from $178.98/mo — but Trava's own pages currently disagree with each other on its clinical-partner name and its cheapest semaglutide price.

Semaglutide:

$117.96/mo starting

Pricing:

Scales with dose

First dose:

Not stated

Flat-rate pricing with a real dietitian included ($119/mo semaglutide, from $175/mo tirzepatide) from a nine-year-old operator — carrying an open FDA warning letter over how it described its own compounded products.

Semaglutide:

$119/mo flat, all doses

Pricing:

Flat

First dose:

5-minute screening

Compounded semaglutide starting at $119/mo — one of the lower headline prices in this batch — from a multi-category telehealth brand that also runs a dedicated Women's Health line, though tirzepatide is no longer part of its catalog and no state list is published. It claims FDA-regulated pharmacy fulfillment, no membership requirement, and 100,000+ patients served, none of which we independently verified beyond the site's own copy.

Semaglutide:

$119/mo

Pricing:

Flat

First dose:

Not stated

Twelve months of semaglutide costs $999 here, paid at the start. That is where the advertised "$83/mo" comes from — the total, divided by twelve — and the site's own code does exactly that division to produce the headline. Month to month is $119, and a year that way is $1,428. So the prepay saves $429, which is a real decision worth making rather than a trick, but the number on the page is not a monthly price and the structured data says it is.

Semaglutide:

$119/mo month to month

Pricing:

Tiered

First dose:

Provider-reviewed within 24 hours

Plans start at a shared $120/mo floor for either molecule from a named physician-founder (Dr. James David Lawrence III) through Promise Pharmacy, covering 44 states — with a $125 short-notice cancellation fee and no dose-tier breakdown beyond the floor price.

Semaglutide:

$120/mo

Pricing:

Not disclosed

First dose:

Not disclosed

One figure to work with — "Plans from $120/mo · confirmed after provider review" — and no breakdown by drug or dose, so there is nothing to budget against until after an intake. The claim that needs checking is the headline: "~15–20% avg. body-weight change", sourced to "multi-center, placebo-controlled national clinical trials of Compounded Semaglutide and Tirzepatide formulations". No such trials exist. Compounded preparations are not FDA-approved and never enter registrational trials; those figures belong to studies of the branded drugs.

Semaglutide:

From $120/mo, not confirmed until after provider review

Pricing:

One "from" price, confirmed only after provider review

First dose:

Not published

A flat-priced provider naming several individual physicians (including a specifically-credited Medical Director) — $125/mo semaglutide, $145/mo tirzepatide as currently displayed — though the site's own strikethrough pricing presentation leaves it unresolved whether that's a standing rate or a promotional one, so confirm at signup.

Semaglutide:

$125/mo (promotional)

Pricing:

Flat

First dose:

Not published

BeyondMD posts 'starting at $125' semaglutide and 'starting at $199' tirzepatide, but on exactly one page it publishes the real range: $139 to $449 a month, plus a $34 consultation fee. Nothing on the site actually sells you anything — every GLP-1 button leads to a form where a specialist calls you back — so your real number arrives by phone. What you get in exchange is the widest menu on this board (both molecules as injections and as tablets, plus brand Wegovy and Zepbound), named clinicians with real bios, and an included nutritionist consult and anti-nausea prescription.

Semaglutide:

From $125/mo

Pricing:

Scales with dose

First dose:

Not published

This record changed completely between checks, and mostly for the better. The founding-member framing that dominated it a week ago is gone: read live on 2026-08-26 KERNX simply says "Semaglutide starts at $129/month and Tirzepatide starts at $229/month. Pricing varies by prescribed dose. No membership fee. No required 3 month plan." What has not gone is the cost outside those figures, and KERNX is unusually straight about it — a provider consultation fee applies when treatment is approved, at $25 for a message-based review, $35 for a standard live visit or $60 for a complex live visit. Two more things this record previously had wrong. It does say where it operates: licensed providers in all 50 states, repeated in its banner and its FAQ. And it publishes a real timeline: a free five-minute assessment, provider review typically within 24 hours, pharmacy processing 1–2 business days and transit 2–3, so most first orders arrive within three to five business days of approval. It also says nothing is charged until a provider approves you.

Semaglutide:

From $129/mo, consult fee extra

Pricing:

Starting rate that varies by dose, plus a separate consultation fee

First dose:

3–5 business days after approval, per its own FAQ

If injections are the blocker, this is the one to look at: DoctorAdam sells GLP-1s only as daily oral tablets, with no injectable in the catalog at all. Semaglutide tablets from $129 a month, tirzepatide tablets from $199, all fifty states, flat monthly pricing with no hidden fees. It also names its clinicians and publishes an Anaheim address. One caution when reading the grid: NAD+ injections carry the same $129 and sit near the semaglutide card.

Semaglutide:

From $129/mo for the oral tablet

Pricing:

Flat monthly, oral tablets only

First dose:

Doctor feedback in roughly 24 hours

The lowest published prices here, on an open storefront with no account, email or intake in the way: microdose semaglutide $99 a month, standard semaglutide $129, microdose tirzepatide $119, standard tirzepatide $149, each once weekly with vitamin B6, plus needle-free oral drops of both molecules at the microdose price. The microdose tiers genuinely cost less than the standard ones, which is not true of every seller. Two things weigh against it. The oral drops carry no published evidence for the route, and milligrams by mouth are not interchangeable with milligrams injected. And the same page advertises retatrutide, badged "GLP-3", as coming soon alongside orforglipron and two oral tablets — retatrutide is investigational and approved for nothing, and "GLP-3" is a nickname rather than a drug class. No state list, no dispensing pharmacy named, and no time to first dose.

Semaglutide:

$129/mo

Pricing:

Flat monthly per product; six products posted openly

First dose:

Not published

Flat and cheap, and almost entirely silent about everything else. Read live on 2026-08-26, compounded semaglutide is $129 a month and compounded tirzepatide $169, unchanged since early August, with no membership and a flat-rate promise the site puts in its own words: unlike clinics that raise fees when doses increase, it keeps one rate for every dosage tier. That is a genuinely good structure and the reason two of its factor scores are high. The rest of the record is built on absences, and we checked them by sweeping the whole homepage: no state list, no shipping or approval window, no cancellation or refund policy, no pregnancy or breastfeeding guidance, and no legal entity anywhere beyond a copyright line. One more thing to hold in view — this is a general online pharmacy rather than a GLP-1 specialist, with erectile-dysfunction pills, migraine and asthma prescriptions and a longevity line sharing the same catalog, so the cheapest number on the page is often not a weight-loss number at all.

Semaglutide:

$129/mo

Pricing:

Flat

First dose:

Not disclosed

FDA warning letter #716508 (Sept. 2025), which names gobioverse.com. A broader longevity platform pricing semaglutide from $129/mo and tirzepatide from $399/mo — but its own homepage can't agree with itself on which states it actually serves.

Semaglutide:

$129/mo

Pricing:

Flat

First dose:

Not disclosed

"Plans from $129/mo · confirmed after provider review" is the whole of the pricing: no drug breakdown, no dose breakdown, nothing fixed before an intake. The homepage contradicts itself on coverage within one screen — a ticker reading "50-state telehealth" beside a stat block reading "0 states telehealth access". And the headline result, "~15–20% avg. body-weight change", is sourced to clinical trials of compounded semaglutide and tirzepatide. Those trials do not exist.

Semaglutide:

From $129/mo, not confirmed until after provider review

Pricing:

A single "from" price, confirmed only after provider review

First dose:

Not published

The flat-price claim is real and the term is the problem. Read live on 2026-08-26, RxPros holds one price across every dose — 0.5mg to 2.5mg semaglutide, 2.5mg to 15mg tirzepatide — with the doctor visit, medication and overnight shipping inside it and no membership fee. But four different figures per molecule appear on that one homepage, and the only place the site attaches a term to any of them is its comparison table, which labels the cheapest pair Paid Annually. The Returns page is where this record changed most. Cancellation through the dashboard is available only after a three-month minimum has been concluded; every order ships as three months of medication up front; canceling in writing before your consultation costs a $99 administrative fee; and once the consultation is complete the order is final and non-cancellable regardless of shipment status. Early cancellation costs the full retail price of what is left on the commitment, an unwarranted chargeback costs $199, and an unpaid balance can go to collections with a 50% surcharge.

Semaglutide:

$134.99/mo

Pricing:

Flat across doses, but sold on a three-month minimum term

First dose:

Approval in 24 hours, delivery in as little as 3 days

A recently-rebranded provider (formerly Piper, now Join Polly) with a flat, dose-independent price for both molecules — $135/mo semaglutide, $199/mo tirzepatide — and one of the few among the providers we track to publicly name its compounding pharmacies (Hallandale Pharmacy, VialsRx).

Semaglutide:

$135/mo

Pricing:

Flat

First dose:

Not published

Two numbers, and they disagree: $127 a month on the homepage, $138 on the pricing page. Neither is final anyway, because the pricing page is titled "Transparent pricing, for members" and then explains that the real figures are "unlocked the moment you create a free NEUVÉ account". The coverage claim disagrees with itself too. What Neuve gets right is the clinical spine — quarterly lab panels from $45, titration described as lab-guided, and a clinician reply quoted within 24 hours.

Semaglutide:

GLP-1 from $138/mo per the pricing page

Pricing:

Gated — real pricing unlocks only after account creation

First dose:

Clinician reply quoted within 24 hours

Cost it both ways and the decision is small and clear. Twelve months of semaglutide is $1,668 monthly against $1,196 on the quarterly plan — $472 apart. Tirzepatide is $2,748 against $1,916, so $832. The seller leads with the quarterly-derived figure, as several here do, but it prints the monthly one on the same line and says under the block that the headline is a quarterly rate. Then it shows the flat price across three ascending doses.

Semaglutide:

$139/mo month to month

Pricing:

Flat

First dose:

Same-day provider review, delivered within days

A $139/mo semaglutide or $199/mo tirzepatide standard rate (after a $69/$129 first-month promo), with a genuinely fair, worked-example refund policy for its multi-month plans — undercut by a pricing page with enough overlapping numbers that the real monthly cost takes real effort to pin down, and no named pharmacy.

Semaglutide:

$139/mo

Pricing:

Flat

First dose:

Not stated

Velvet Rx is quick to price-check and slow to verify, which is an awkward combination when you have twenty minutes. Its homepage carries three figures before any intake — injectable semaglutide as low as $139 a month, injectable tirzepatide as low as $179, an oral GLP-1 as low as $189 — and the oral option is genuinely uncommon on this page. But 'as low as' governs all three and is never resolved anywhere: no dose ladder, no plan length, no billing cadence, and no pricing page to check, because /pricing and /weight-loss both return 404. The homepage is the only page on the site with a number on it. That matters practically, not philosophically: providers on this page that do publish ladders often double between a starting dose and a maintenance dose, so a floor with no ladder is an unanswered question about your real monthly cost. The other gaps are quick to list — no compounding pharmacy named, no clinician named, no state coverage published — and its cancellation FAQ asks 'How do cancellations and refunds work?' then answers 'our care team will guide you with personalized support', which is not a policy. The one thing that did check out cleanly: FDA's warning-letter index, screened for both Velvet Rx and its operator Rocket Health Inc. with a positive control in the same pass, returns nothing.

Semaglutide:

From $139/mo (its own 'as low as' floor)

Pricing:

Floor only — no ladder published

First dose:

Not published

A month-to-month, no-subscription compounded shop — from $139.99/mo semaglutide, $179.99/mo tirzepatide — that requires a separate $50 Zoom video consultation before treatment begins.

Semaglutide:

From $139.99/mo

Pricing:

Tiered

First dose:

Not published

Cost a year and the two molecules diverge hard: semaglutide is $1,740 on subscription, tirzepatide $3,780. The homepage prices both under one figure — "from $145/mo" — so the difference only appears on the treatment page. Add $49 for the consultation, or 10% more across the board if you buy one-time rather than subscribing.

Semaglutide:

$145/mo on subscription

Pricing:

Tiered

First dose:

Overnight delivery after the $49 consultation

The lowest published starting price found this round — $147/mo semaglutide, $199/mo tirzepatide, one flat number with 'no membership costs, no hidden fees' — but a working mom won't find that number on the site she lands on first; it only shows up after being routed to a separate signup app running a countdown-timer sale.

Semaglutide:

$147/mo

Pricing:

Flat

First dose:

Not disclosed

A fully itemized pricing table — as low as $96/mo semaglutide or $142/mo tirzepatide on the annual plan — from the same medical group behind Cora Health, another new addition this batch.

Semaglutide:

$149/mo month-to-month ($96/mo on the 12-month plan)

Pricing:

Tiered by plan length

First dose:

Provider reply in under 24 hours

Flat compounded pricing with the post-introductory number actually printed: $149 a month for semaglutide and $229 for tirzepatide, the same at every dose, after intro rates of $119 and $199. For planning purposes that flatness is the useful part — a titration step-up does not change the bill, so the number you budget in month one is the number in month six. All 50 states, and consultation, prescription, medication, shipping and support are inside the price. Watch the word "from" on every figure: the site says dosage and titration can move what you pay.

Semaglutide:

$149/mo after the intro period

Pricing:

Flat

First dose:

Not published

A twenty-year weight-loss operator rather than a telehealth startup, selling compounded semaglutide at $149 a month to month and tirzepatide at $239, medication and clinical care in one price with no separate membership fee. The cheaper $116 and $159 figures it leads with are three-month plans, and there is a catch its own FAQ spells out: those plans bill every ten weeks, not every twelve. That is 5.2 charges a year instead of 4, which turns an advertised $116 a month into roughly $151 a calendar month. Read it as a real discount, just a smaller one than the number suggests. It ships to all 50 states, holds a BMI floor of 26, and excludes anyone pregnant or breastfeeding.

Semaglutide:

$149/mo month-to-month ($116/mo on a 3-month plan)

Pricing:

Flat

First dose:

Not disclosed

A genuinely transparent tiered-pricing shop — as low as $149/mo semaglutide or $199/mo tirzepatide on the annual plan — with press mentions and bilingual support, though the oral tablet's own pricing wasn't fully itemized.

Semaglutide:

$149-219/mo depending on plan length

Pricing:

Tiered by plan length

First dose:

Not published

FDA warning letter #728291 (Jun. 2026), which names orderlymeds.com. One of the few sites in this round to publish real cash prices for both compounded ($149/mo semaglutide, $299/mo tirzepatide) and FDA-approved brand-name options (Wegovy® $1,839/mo, Zepbound® $1,498/mo) — a named Chief Medical Officer, and licensed in all 50 states. It also cites customer-reported outcomes (125k patients, 1M+ pounds lost) rather than leaving weight-loss claims unsourced.

Semaglutide:

$149/mo standard

Pricing:

Tiered

First dose:

Not published

A granular GLP-1 menu — microdose from $129/mo, semaglutide from $149/mo, tirzepatide from $249/mo, plus an exclusive combined 'GLP-Squared' injection — all stated as all-inclusive, though the site doesn't itemize exactly what that covers.

Semaglutide:

Starts at $149/mo, all-inclusive

Pricing:

Tiered

First dose:

Not published

$199 semaglutide, $249 tirzepatide, flat at every dose, billed on a genuine calendar month. The $99 and $149 on the homepage are first-order only — budget the full rate from month two. Oral dissolving tablets at $149 and $199 if you want to skip the needle. Subscription is mandatory on every GLP-1 despite a one-time option in the FAQ, and the injectables are not in the catalog: you reach them through the quiz or a direct link.

Semaglutide:

$149/mo oral ($199/mo injection)

Pricing:

Flat

First dose:

Not published

Telehealth GLP-1 programs in all 50 states from $149 a month, including a dedicated microdose protocol alongside standard semaglutide and tirzepatide. That figure is a floor rather than a rate, it is labeled a limited-time offer, and no treatment page publishes a price for any specific molecule, so the real cost is not knowable until you finish a two-minute eligibility check. Superior Remedies charges nothing if you are not approved, titrates the dose to how you respond rather than shipping a fixed refill, and attributes its compounding to state-licensed pharmacies it does not name.

Semaglutide:

From $149/mo (floor)

Pricing:

Flat

First dose:

Not published

Compounded semaglutide at $149 and tirzepatide at $183, both advertised as sale prices against $299 and $399, with no membership fee and pharmacies described only as USA-based. NativeMed carries an FDA warning letter of its own — issued to NativeMed LLC dba NativeMed on 8 June 2026, MARCS-CMS 728287, for false and misleading claims and misbranding in telehealth. We list it and disclose the letter rather than dropping it, because a letter tells you something a reader should weigh and only a shutdown ends a listing. The storefront also sells NAD+ injections and generic sildenafil, tadalafil and trazodone alongside the GLP-1s, so it is a general telehealth catalog rather than a weight-loss practice.

Semaglutide:

$149/mo (sale, regular $299)

Pricing:

Flat

First dose:

Not published

Novi's month-to-month rates are $149 semaglutide and $179 tirzepatide, flat at every dose — but almost every number the site advertises is a prepay term price divided by its term. The '$88/mo' headline on Novi's own product page is the twelve-month row, and its homepage quotes '$133/mo' under a countdown, a figure that is not a monthly price on either product page. Its intake then serves a higher variant again. Its Terms require a three-month non-refundable commitment while its help center says there are no commitments at all, so the two things you most need to know — what leaves the account, and when you can stop — are the two things Novi contradicts itself on.

Semaglutide:

$149/mo

Pricing:

Flat

First dose:

Not published

Compounded semaglutide at $149 a month and tirzepatide at $279, flat across every dose the site lists, from a women's clinic that treats weight as one lane among hormones, perimenopause, gut and skin rather than the whole product. There is a genuine 2.5mg microdose tirzepatide line at $249, which is worth reading twice: it costs only $30 less than the full-dose plan. The prices are on open pages with no quiz in the way, and the BMI floor of 27 is stated up front. Two things to know before you commit. Its own semaglutide page describes the same plan as both month-to-month and four-week, so ask which one your card is on. And the cancellation page linked twice in the top navigation is completely blank.

Semaglutide:

$149/mo

Pricing:

Flat

First dose:

Not disclosed

Rehydra+ Wellness is the one provider added here that charges more as your dose goes up, and it is unusually open about it: its storefront publishes a complete dose-by-duration matrix, so you can see before signing up that compounded semaglutide runs $149 for four weeks at the 0.25 mg starting dose and $289 at 2.5 mg, while tirzepatide runs $219 at 2.5 mg and $649 at 15 mg. That transparency is genuinely useful, and it also means the entry price is the least representative number on the page — if you titrate to an effective dose, your cost roughly doubles. Six-month tier plans bring the per-month figure down to $119 and $169, but they are six-month commitments rather than rolling plans. It is a small San Antonio operation founded in 2023, offering a free 15-minute telehealth call and free shipping. The two real gaps: it names no pharmacy and no individual clinician, and its own pages disagree on coverage — the weight-loss landing page says 19 states and lists 19, while the homepage says 20.

Semaglutide:

$149/mo

Pricing:

Scales with dose

First dose:

Free 15-minute telehealth call

There is no way to price Believe without applying to it. Its three GLP-1 treatment pages were read end to end and carry no dollar figure at all; the only number on the homepage is a badge promising nothing is charged if you are not approved. Behind the eligibility gate the menu is four plans, each flat at every dose: semaglutide $149 a month against a struck-through $249, tirzepatide $229 against $299 and marked most chosen, a microdose at $199, and a daily oral at $229. Those are competitive figures with two complications. The microdose costs $50 a month more than standard semaglutide, the reverse of what a lower dose implies. And two of the four plans never name a molecule, so you would be choosing between products without being told which drug is in them. It claims fifty-state care without listing states, names no pharmacy, and publishes no time to first dose.

Semaglutide:

$149/mo after an approved intake

Pricing:

Flat at every dose — but no price is public until you are approved

First dose:

Not published

Compounded semaglutide from $149 a month and tirzepatide from $199, with a genuine microdose line at $129 and a dissolving oral tablet at $169 — a wider catalog than most, and it includes hormone therapy for women from $69. The number to ignore is the one it leads with. 'Starting at $99/mo' runs across every page, and no GLP-1 on the site costs $99: the cheapest is the $129 microdose. The $99 belongs to its NAD+ nasal spray. Two more gaps worth knowing. Every price is a floor, with no ongoing rate published. And it names no company anywhere — no LLC, no address, nothing in the terms or privacy policy.

Semaglutide:

From $149/mo — a floor; no month-to-month rate is published

Pricing:

Flat by product; no month-to-month rate published

First dose:

Not published

$149/mo semaglutide or $199/mo tirzepatide on its recommended Monthly Plan, from two named compounding pharmacies, with a real published cancellation policy — one of the more transparent compounders reviewed, though no time-to-first-dose figure or state list is published.

Semaglutide:

$149/mo

Pricing:

Flat

First dose:

Not stated

One of the few candidates verified this pass spanning both a cheap compounded entry ($99/mo semaglutide) and a real brand-name Wegovy/Zepbound fallback, billed once per plan rather than monthly — text-only consult, no video visit, but no stated turnaround time.

Semaglutide:

$99/mo

Pricing:

Scales with dose

First dose:

Not disclosed

LegitScript-certified and available in all 50 states at $149/mo ongoing (after a $124 first month) for compounded semaglutide — but it's a broad IV-therapy-and-hormone platform first, its own homepage banner prices the same program differently than its product page, and tirzepatide isn't offered as a compounded option. It also runs mobile IV therapy (Texas only), hormone replacement, and hair regrowth under the same brand, dispensing through 503A and 503B U.S.-licensed pharmacies per its own claim.

Semaglutide:

$149/mo

Pricing:

Scales with dose

First dose:

Not stated

Texas only, and it prints the disclosure most of this batch omitted: "$99/mo + medication cost" on the Wegovy tier, stating on the card that the fee buys the service and the drug is billed on top. Compounded semaglutide is $149 as a weekly vial or a daily tablet, with brand-name Wegovy and Zepbound available — their medication costs unpublished.

Semaglutide:

$149/mo for the compounded vial or tablets

Pricing:

Flat monthly; the brand tier is a service fee plus medication

First dose:

Not published

The pricing is workable: semaglutide from $149 a month, tirzepatide from $199 against a struck-through $299, each itemizing the visit, prescription, delivery and check-ins — the kind of flat structure that survives a titration without surprises. The problem is in the policies, where the company's own address appears three times as "123 Example Street, Suite 100, Your City, WI, 92308". An unfilled template placeholder, live, on a site dispensing prescription medication.

Semaglutide:

From $149/mo

Pricing:

Flat monthly, one price per molecule

First dose:

Not published

Semaglutide is advertised as low as $149 a month and tirzepatide at $199, and after previously disagreeing with itself the site now quotes the same figures on the homepage and each drug page. Read both as floors rather than rates. No ceiling is published, no dose ladder appears anywhere, and the three- and six-month bundles carry stack discounts that are never quantified, so nothing on the public pages lets you work out the cost once the dose settles. The clearest gap is the memberships page, which names tiers and publishes no price for any of them despite the memberships appearing to be how the programs are sold. RENN is a California-based virtual weight-loss and performance clinic that also offers NAD+ therapy and delivers medication directly. The compounding pharmacies are never named, no time to first dose is given, and the only coverage statement is that the website may be accessed from all fifty states — a claim about the website rather than about licensure.

Semaglutide:

From $149/mo (floor)

Pricing:

Floor only — no ceiling or dose ladder published

First dose:

Not published

Take the product cards and the arithmetic is fine — semaglutide from $149 against a struck $249, tirzepatide from $249 against $299, with the visit, prescription, delivery and check-ins included. Take the rest of the page and it disagrees with the cards: the hero and the eligibility widget both advertise "from $99/mo", a figure that appears nowhere else. The header says "10k+ Trusted by thousands of members" twenty lines above a counter reading "0 + Patients supported".

Semaglutide:

From $149/mo

Pricing:

Flat monthly per molecule, contradicted by the hero

First dose:

Free 2-3 day shipping, per the site

One flat $149/mo injection price (or $249/mo dissolvable tablet) covers either molecule since FeelGood prices by form, not by drug — built on the OpenLoop Health backbone with free shipping and no membership fee, though states served and its compounding-status disclosure are both thinner than category norms.

Semaglutide:

$149/mo

Pricing:

Flat

First dose:

Not disclosed

A Dallas-area mobile wellness business, not a nationwide telehealth brand — $149/mo semaglutide and $189/mo tirzepatide, flat at every dose after a prior pricing conflict got re-checked. No online quiz, no stated time-to-first-dose, and no shipping outside Texas.

Semaglutide:

$149/mo

Pricing:

Flat

First dose:

Not disclosed

The billing cycle is stated in the same sentence as the price, so the year is countable without guesswork: thirteen charges of $149 is $1,937 for semaglutide and $2,587 for tirzepatide. Both are founding rates the site says will rise to $179 and $249 — $2,327 and $3,237 a year. What you cannot read is any of its legal documents, because they are the homepage with a different title on the tab.

Semaglutide:

$149 per 4 weeks

Pricing:

Flat

First dose:

Days after the online evaluation

The lowest advertised starting price checked this pass, but a floor rather than a flat rate, with no stated turnaround time or intake format — three real unknowns for a working parent trying to plan around it.

Semaglutide:

From $149/mo

Pricing:

Scales with dose

First dose:

Not disclosed

The most useful idea in this group sits on the least trustworthy page. LunaRx sells muscle-protective care — GLP-1 with peptides and "a structured off-ramp — metabolic recomposition, not another forever prescription" — bilingually, under a named nurse founder. Then its three patient testimonials, names and durations intact, turn up word for word on a different company's site. Its own price is also stated twice: the page title says $199, the hero says $149.

Semaglutide:

From $149/mo per the hero; the page title says $199

Pricing:

One "from" price, stated twice at two figures

First dose:

Not published

Two prices for the same thing, on the same screen, and no way to tell which one is real: the header says "GLP-1s from $119/mo", the card beneath says "From $149/mo". The testosterone line repeats the trick, $89 against $99. One mismatch is a typo; two in the same header is a page nobody checked. The bilingual English and Spanish build is a real advantage — but there is no state list, no address, and no tirzepatide price at all.

Semaglutide:

From $149/mo per the treatment card

Pricing:

Stated twice on one screen, at two different figures

First dose:

Not published

Costed over a year: $1,799.64 paying monthly against $1,349.97 committing to twelve, a gap of $450, and the same price whichever molecule you take. Both divisions are exact. What is not exact is the banner above the selector, which promises plans "Starting at $249.97/Month" — a figure that appears nowhere in the plans and, it turns out, appears word for word on another seller's site too.

Semaglutide:

$149.97/mo

Pricing:

Flat

First dose:

Days after the online consultation

Trellis Vitality is the cheapest genuinely-disclosed option on this page: $150 a month for compounded semaglutide and $199 for tirzepatide, month to month, with every dosage available at the same price and no membership fee, no consult fee and a $0 assessment. Commit for three or six months and those fall to $140/$133 and $189/$179. It names the pharmacy that compounds the medication — Vials Rx, described as a US state-licensed, cGMP-compliant facility — which is the disclosure most of its cheaper competitors skip, and it covers all 50 states with board-certified clinicians reviewing intake. The caveats are about what it doesn't sell and doesn't say. There is no FDA-approved brand option, no oral formulation, and none of its pricing appears on the homepage at all — you have to reach the GLP-1 product page to find a single number, which makes it look more opaque than it actually is. There is also no postpartum, breastfeeding or PCOS content anywhere.

Semaglutide:

$150/mo

Pricing:

Flat

First dose:

$0 assessment, clinician review

Three clear prices — $150, $240, and $150 for an oral liposomal semaglutide — attached to statistics that do not survive checking. The "94.6% success rate" is footnoted to "approximately 66,260 Remedy Meds members", the white-label platform this site runs on rather than its own patients; a second footnote says 50,000. The live review widget reads six reviews, one member, beneath "1M+ Users on GLP-1".

Semaglutide:

From $150/mo

Pricing:

Flat monthly per product

First dose:

Not published

FDA warning letter #716501 (September 2025), which names getzealthy.com, and in April 2026 the FTC and DOJ moved to seize the company and freeze its assets. Read both before anything else here. On the money: read live on 26 August 2026, self-pay semaglutide is advertised at "as little as $151/month" and brand Ozempic, Wegovy, Zepbound and Mounjaro at "as low as $25/month" with insurance — two figures that are not comparable, because the second is a copay that depends on your plan and the same paragraph quotes $1,349 without coverage. No tirzepatide price is published anywhere. A "$96 off your first month" banner runs site-wide and its own policy confirms the rate reverts to full afterward. Cancellation is self-serve and documented step by step, but there is no prorated refund, medication is final once shipped, and the policy warns members may be required to sign up for multiple months to keep supply continuous. Four months after the federal petition it is still trading normally under the same entity, FitRX, LLC dba Zealthy, at the same New York address the FDA letter used.

Semaglutide:

From $151/mo self-pay

Pricing:

"As low as" floor, promotional first month

First dose:

Same-day appointments advertised

One number, and it genuinely covers everything: PepHaus states that its flat monthly price includes the provider visit, the medication, needles, alcohol swabs and messaging with the care team. Semaglutide from $152, tirzepatide from $215, both published twice on the site and agreeing with each other. It also puts a Certificate of Analysis on every vial, which is the most concrete answer on this page to what is actually in a compounded product. Watch the hero figure: "From $143/mo" is sermorelin and glutathione.

Semaglutide:

From $152/mo, all-inclusive

Pricing:

One flat all-inclusive monthly price

First dose:

Provider review within 24 hours

A straightforward compounded-only shop with real prices for every tier on the public site — no intake gate — but the 'Starter Pack' name is a trap if you assume it behaves like the regular 3-month plan.

Semaglutide:

$159/mo (1-month), $119/mo effective on the 3-month plan

Pricing:

Tiered by plan length

First dose:

Not published

Coby publishes its whole dose-scaling ladder up front, which is rarer than it should be: read live on 2026-08-26, compounded semaglutide runs $159, $199, $229, then $249 and holds there, and tirzepatide runs $239, $299, $329, $379, then $439. Every rung is unchanged since early August. It also answers the two questions most sellers dodge. On video, its FAQ says outright that unless your state requires one, no video visit is needed and your provider reviews everything online. On coverage, it names the four states it does not reach — Arkansas, Louisiana, Mississippi and New Mexico — instead of staying vague. Two things go the other way. Coby's month is four weeks by its own arithmetic, since it sells a three-month bundle as twelve weeks and a six-month bundle as twenty-four, so a year is thirteen bills rather than twelve. And changing your mind costs money: canceling before the prescription reaches the pharmacy deducts a $50 non-refundable visit and clinical fee from the refund, and once it has been sent, the order cannot be changed at all.

Semaglutide:

From $159/mo

Pricing:

Scales with dose

First dose:

Not stated

A comprehensive-care shop that puts real numbers on the homepage: read live on 2026-08-26, compounded semaglutide is $160 a month or $130 on a three-month plan, tirzepatide $199 or $163, unchanged since early August. Its FAQ says that single figure covers medication, physician care, support, shipping and all supplies with no membership, and unlimited provider messaging is the thing it sells hardest — message your provider anytime, dose changes at no extra cost. Two answers here are better than most of this roster gives. It serves all fifty states and the District of Columbia. And it tells you exactly where a video visit is required rather than leaving it vague: most states can start without one, but Kansas, Louisiana, Mississippi, New Mexico and West Virginia need a brief video or audio visit first. One thing to pin down before you pay is the period — the plan selector says per month, while the refill schedule on the same page says shipped every 28 days, and thirteen refills a year is not the same bill as twelve.

Semaglutide:

$160/mo month-to-month

Pricing:

Two plan lengths; the cheaper one is billed every three months

First dose:

Not published

An MD-led, budget-friendly compounded shop that names its pharmacy partners — around $165/mo semaglutide or $200/mo tirzepatide standard — though pricing is packaged in 12-week blocks and the advertised rate is a new-patient discount off a higher renewal price.

Semaglutide:

$165/mo standard (12-week package), $133/mo new-patient

Pricing:

Tiered (12-week packages)

First dose:

Not published

Its homepage says weight loss starts "for as little as $287/month"; its weight-loss page prices compounded semaglutide at "as low as $167/Month". The homepage overstates its own floor by $120, which is the rare pricing error that costs the seller rather than the reader — and a reason to click through rather than take the front page at its word. Both molecules come as a weekly injection or a once-daily sublingual tablet at the same price. The branded pens carry prices but are marked Coming Soon.

Semaglutide:

$167/mo for the compounded injection

Pricing:

Flat "as low as" price per form, injection or sublingual

First dose:

Not published

The one confirmed nationwide pick in this batch — all 50 states, explicitly stated — with a $168/mo semaglutide, $268/mo tirzepatide month-to-month rate that only drops to $129/$199 on a full year prepaid upfront.

Semaglutide:

$168/mo

Pricing:

Tiered

First dose:

Same-day provider review (site's own claim)

The arithmetic that stands out: tirzepatide costs the same as semaglutide here, both from $169 a month, where the dual agonist normally carries a $50 to $100 premium. Over a year that is a real difference. Lighter You also names four compounding pharmacies outright — RedRock, Health Warehouse, Precision Compounding and Triad Rx — with websites, addresses and phone numbers, where most of this roster names none. All fifty states plus Washington, D.C.

Semaglutide:

From $169/mo

Pricing:

Flat monthly, same price for both molecules

First dose:

Not published

The sum is done for you here, which is rare. Ninety-nine dollars a month is the program — every visit, the check-ins, the coaching, 3D body composition testing — and the medication is a separate line from $70. So budget about $169 a month, or roughly $2,028 a year, with one caveat: the $70 is itself a starting figure and the ceiling is not published.

Semaglutide:

$169/mo — $99 program plus medication from $70

Pricing:

Tiered

First dose:

After the program intake and a doctor visit

Compounded semaglutide at $169 and tirzepatide at $249, with genuine microdose lines beneath both at $149 and $199, all on an open pricing page you reach without an intake quiz. It names its clinical group and its pharmacy outright, which most of this roster will not do. Two cautions before you compare it with anything else here. Its pricing page puts a per-month suffix on its three-month and six-month columns, where the number is actually the whole period's total — its own product pages divide those same figures by six. And nowhere does it say how long a billing period is, so the prices above are per period, not per calendar month.

Semaglutide:

$169 per billing period — length not disclosed

Pricing:

Flat

First dose:

Not disclosed

A single semaglutide-plus-B12 product (SKU COMP-GLP1 on Actin's own site) with no tirzepatide, priced $116-169/mo depending on plan length — pulled directly from the site's own client-rendered pricing data — with a fully async intake but no stated time-to-first-dose and no LegitScript badge. Read the low end carefully: $116 is the per-month equivalent of a six-month plan paid in a single charge, and $143 the three-month equivalent. Month to month, with no commitment, the price is $169.

Semaglutide:

$169/mo

Pricing:

Tiered

First dose:

Not disclosed

For planning purposes the tirzepatide line does not resolve. Its card reads "$149 first month. Then $199/mo on 8-week cycles" — a per-month figure attached to an eight-week billing period in one sentence, with no conversion given anywhere, so you cannot build a yearly number from it. Beside that sits "Tier 2 from $399", meaning $199 is the entry tier and the bill climbs with your dose. Semaglutide is cleaner: $169 a month, described as priced by weekly dose. Two other things to check before you compare. CLYR contradicts itself on coverage, carrying three separate "Ships to 47 States" badges while its FAQ says services are available in all 50. And its compounding pharmacy may substitute vitamin B6 for the B12 the product is named after, based on ingredient availability. What is genuinely good: the consultation, prescription, ongoing dosing adjustments, the vitamin and free priority shipping are all inside the price, cancellation is stated as anytime with no penalties, and you get a full refund if a provider finds you ineligible.

Semaglutide:

$169/mo, priced by weekly dose

Pricing:

Dose-tiered, and the tirzepatide billing period is self-contradictory

First dose:

Not published

A science-forward compounded shop with a broad peptide catalog and flat dosing — $170/mo semaglutide, $210/mo tirzepatide ongoing — but the homepage 'as low as' price is a promotional rate, and the compounding pharmacy isn't named.

Semaglutide:

$170/mo ongoing (injectable), $140/mo first month

Pricing:

Flat

First dose:

Not published

Flat, same-price-every-dose compounded semaglutide ($174/mo) and tirzepatide ($264/mo) from a named physician group (Beluga Health, Dr. Jonah Mink) and a named compounding pharmacy (F&F Pharmacies Inc., which the page says runs lot-level quality checks tracked back to your patient file) — undercut by a states page whose own numbers don't add up, and a checkout that includes an unbroken-out "HealthiCare Service (20%)" line alongside the flat rate.

Semaglutide:

$174/mo

Pricing:

Flat

First dose:

Not disclosed

The most transparently tiered pricing found in this batch — as low as $99/mo semaglutide or $135/mo tirzepatide on the annual plan, with every tier itemized publicly — from a platform with a thin 36-review Trustpilot count so far.

Semaglutide:

$175/mo month-to-month ($99/mo on the annual plan)

Pricing:

Tiered by plan length

First dose:

Provider review in about 24 hours

A $175/mo semaglutide, $199/mo tirzepatide compounded option carrying its own FDA warning letter (September 2025) for a 'same active ingredient as Wegovy & Ozempic' claim the FDA called misleading.

Semaglutide:

$175/mo

Pricing:

Tiered

First dose:

Same-day provider review (site's own claim)

Publishes the whole ladder, so the annual math is checkable: $2,100/yr month-to-month or $1,440 prepaid. Currently moot — as of 2026-08-21 every signup CTA returns a 404.

Semaglutide:

$175/mo

Pricing:

Flat within a cadence; the cadence you pick sets the rate

First dose:

Site claims within 3 days of the questionnaire

The number on the page is a prepay. Read live on 2026-08-26, GOAL.MD's semaglutide page leads with $99 a month and its tirzepatide page with $159 — and both are 12-month prepaid equivalents, $1,188 and $1,908 handed over up front. Month to month, the same two medications are $179 and $249. The site does say so, in the same sentence, but second. Everything around that pricing is unusually clean for this roster: a named physician with a searchable NPI rather than an anonymous clinical network, "No Auto-Billing. Ever." with a stated check-in before every renewal, a 3-minute online medical visit with no video call mentioned anywhere in the copy, and a published timeline — physician decision in about 24 hours, free shipping in 2–3 days. Two corrections to make if you are comparing: it serves 48 states rather than the whole country, and its brand-name lane is a forwarding service where you pay GOAL.MD $95 a month for supervision and the manufacturer program directly for the drug.

Semaglutide:

$179/mo month-to-month

Pricing:

Four prepay tiers — the advertised rate is the 12-month prepay

First dose:

Physician decision in ~24 hours, ships free in 2–3 days

A clean, all-inclusive flat-price shop — $179/mo semaglutide, $249/mo tirzepatide, unlimited follow-ups included — with no brand-name fallback and no published time-to-first-dose.

Semaglutide:

$179/mo all-inclusive

Pricing:

Flat

First dose:

Not published

Every price TrimRx advertises is a starting price, and it publishes no ending one. The homepage shows 'Starting at $179' semaglutide and 'Starting at $259' tirzepatide; a second TrimRx funnel was advertising 'Starting at $149' the same day; trimrx.com/pricing renders blank; and the Terms contain no pricing at all. There is no ongoing rate on this site to find. The flat-at-every-dose promise is real — checkout says 'Same Price. All Dosage Levels.' — but the intake runs 35 screens and never once asks whether you are pregnant or breastfeeding.

Semaglutide:

From $179/mo

Pricing:

Flat

First dose:

Not published

A rare compounded-plus-brand shop with five real price points disclosed up front — $179/mo compounded semaglutide up to $1,086/mo brand Zepbound — though the oral tablet's exact molecule split isn't fully clear.

Semaglutide:

$179/mo compounded, $997/mo brand Ozempic®

Pricing:

Tiered

First dose:

Not published

A flat-price compounded shop — $179/mo semaglutide, $259/mo tirzepatide, same price at any dose — though the site doesn't itemize what's actually bundled into that number.

Semaglutide:

$179/mo, same price any dose

Pricing:

Flat

First dose:

Not published

A genuinely async start in 45 states, wrapped around a price page that advertises one molecule and hides the other: tirzepatide runs $329 a month, 84% over the headline, and you cannot find that out without starting the intake.

Semaglutide:

$179/mo

Pricing:

Flat by dose (promotional); prepay tiers

First dose:

2 days or 7–10 (site conflicts)

FDA warning letter #721449 (Feb. 2026), which names goodgirlrx.com. No required video visit and both molecules across six formats — injectable, microdose, oral dissolving tablets — all-inclusive from $134/mo, from a brand barely a year old.

Semaglutide:

$179/mo on the 1-month plan ($134/mo on the 12-month annual plan)

Pricing:

Tiered

First dose:

Not stated

A broader wellness platform with GLP-1s starting from $179/mo semaglutide and $255/mo tirzepatide, alongside a longevity catalog — though the 'From' pricing means the real ongoing cost isn't fully confirmed on the public pages.

Semaglutide:

From $179/mo

Pricing:

Tiered

First dose:

Not published

A needle-free oral tablet option alongside injections for both molecules, all 50 states cleanly disclosed, and brand-name access when prescribed — alongside a self-reported '15-22% weight loss' marketing claim its own disclaimer admits isn't clinical data.

Semaglutide:

$179/mo

Pricing:

Tiered

First dose:

Not disclosed

A surgical practice rather than a telehealth brand: a Hollywood, Florida bariatric center with a named surgeon, offering sleeves and bypasses alongside the injections, and same-day appointments. Semaglutide is $69 a week or $179 a month; tirzepatide starts at $279. Two things to price carefully. The package labels overstate their own length — "2.5-Month (10 Weeks)" is 2.3 months — and the practice markets retatrutide, which is not approved anywhere for anything.

Semaglutide:

$179/mo for the monthly program

Pricing:

Weekly, monthly or multi-week package

First dose:

Same-day appointments available

For a Texas mom short on time this is genuinely fast — same-day provider review, then one to three business days to the door, both published on its own page rather than implied. The pricing picture is also better than this record previously showed. Read live on 2026-08-26, the pricing page states the standing month-to-month rate outright: $179 a month for compounded semaglutide at any dose, free shipping, cancel anytime with no minimum term, dropping to $149 on a three-month plan or $129 on six — and both longer plans are billed as monthly charges rather than taken as one upfront hit, which the site sells hard as "No $600–$800 upfront cost." Every tier includes a monthly one-to-one provider call, a nutrition guide and a meal plan. Two things to keep straight. The $79 in the marketing is a first-month figure, and the pricing page quotes a different first-month figure again at $89.50 with a code. And this is a Texas practice — its pharmacy and providers are licensed in Texas and nowhere else, which ends it for everyone in the other forty-nine states.

Semaglutide:

$179/mo month-to-month

Pricing:

One rate at every dose, three plan lengths, all billed monthly

First dose:

Same-day review, then 1–3 business days

A flat $179/mo semaglutide and $249/mo tirzepatide regular rate (behind a $99/$135 countdown-timer intro) with no consultation or membership fees, free 2-day shipping, and named pharmacy partner VialsRx — though Bodi Envi itself never confirms its own state coverage beyond the pharmacy's separate 50-state license.

Semaglutide:

$179/mo

Pricing:

Flat

First dose:

Free 2-day shipping (approval timeline not disclosed)

An affiliate partner with real per-drug starting prices — $179/mo semaglutide, $279/mo tirzepatide — undercut by its own FAQ advertising a different $249/mo 'program' figure, non-refundable fees collected before the consult, and no disclosed state-availability list. The funnel (go.livbody.com) is a Framer-built, server-rendered landing page for parent brand LivBody, LLC, founded by Paige Hathaby and based in Henderson, Nevada — confirmed directly from its raw served HTML rather than a marketing claim.

Semaglutide:

$179/mo

Pricing:

Flat

First dose:

Not stated

Publishes a floor and calls it a price — read live on 2026-08-21 the site says "From $179 /mo" for semaglutide and "From $329 /mo" for tirzepatide, and the word from is doing real work in both. No dose ladder, no maintenance rate and no ceiling appear anywhere on the public site, which means the number you would actually pay once you titrate up is the one piece of information the page does not give you. That matters more here than on a flat-price seller, because a floor tells you only where the billing starts. On the disclosure side it does better than several listings here: it names its operating entity, vyrarx, Inc., in its own Terms, and it screened clean against the full live FDA warning-letter index with four positive controls firing in the same pass. No state list is published, and nothing on the site addresses pregnancy, breastfeeding or postpartum timing.

Semaglutide:

$179/mo

Pricing:

From-price floor, no ceiling published

First dose:

Not published

$183/mo semaglutide or $268/mo tirzepatide, with quarterly labs and coaching genuinely bundled in, four named pharmacies, and no live video visit described anywhere in its published intake — one of the better-documented options for a working mom's calendar, though pricier than the rock-bottom tiers.

Semaglutide:

$183/mo

Pricing:

Flat

First dose:

Not stated

Dose-scaling pricing from $189/mo (starting dose) up to $389/mo (top tirzepatide dose), confirmed by pulling the site's own production pricing and states data directly — genuinely specific 48-state coverage (all but AL and MS) and no hidden cancellation fee found in its own Refund Policy.

Semaglutide:

$189/mo

Pricing:

Scales with dose

First dose:

After async provider review (turnaround not disclosed)

A same-day-provider-access platform offering compounded tirzepatide from $189/mo alongside brand-name Ozempic/Zepbound/Mounjaro access — but no compounded semaglutide option, so semaglutide-specific readers pay brand-name prices starting at $345/mo.

Semaglutide:

Ozempic® from $345/mo

Pricing:

Tiered

First dose:

Same day (instant provider match, per the site)

The monthly plan is not monthly. Read live on 26 August 2026, PrescribedRx now sells both GLP-1s month to month — semaglutide at $189 and tirzepatide at $276 — which is a real improvement on the prepay-only structure it had in August. Then read its Purchase Terms: "Month to Month subscriptions automatically renew every 20 days. 3 Month subscriptions automatically renew every 10 weeks." A twenty-day cycle means about eighteen charges a year rather than twelve, so $189 a month is nearer $3,450 a year than $2,268 — roughly half again what the label implies. The prepaid tiers are still the best value and still carry the one genuinely honest number in this screen: $420 buys two paid months plus a free third, which is $140 across the three months it covers, and the site advertises the higher figure, $210, because it divides by the two paid months. Against that, the plan pages promise a "Money-back guarantee" while the Purchase Terms say an order is final and non-refundable once a consultation is completed and a prescription issued, with an administrative fee of up to $99 even for canceling beforehand. And PrescribedRx says of itself that it "is a patient management and marketing platform," does not employ physicians, does not dispense medication and does not compound anything.

Semaglutide:

$189/mo month to month

Pricing:

Monthly or prepaid, and the billing period is not a month

First dose:

"Access to doctor in 48h", per its own plan pages

Its own semaglutide page gives two different prices for the same product. The pricing cards read $189 a month or $399 for three months, and the paragraph directly beneath reads $167 a month or $467 for three — and since $467 is the tirzepatide total, the text appears to be leftover copy from the other product. The tirzepatide page has an arithmetic problem of its own, advertising $467 as equivalent to $149 a month when three months at $467 is $155.67, and there is no monthly tirzepatide plan: a three-month minimum applies and renews quarterly. The terms compound it by referring repeatedly to a different company's website and listing prices matching nothing on the product pages. What is genuinely strong is easy to miss underneath. VevaRX enumerates thirty-six states by name, locks the price before intake and holds it at every dose, and the quoted figure includes the provider visit, the supplies and free two-to-three-day shipping — the only delivery timeline any seller in this batch publishes.

Semaglutide:

$189/mo

Pricing:

Flat at every dose; tirzepatide sold only as a three-month plan

First dose:

2–3 days' shipping once approved

A concierge functional-medicine platform that bundles a 91-biomarker lab panel into GLP-1 care — $189/mo semaglutide, $339/mo tirzepatide (both $149 the first month) — but with no stated turnaround time, likely slower than a bare async intake.

Semaglutide:

$189/mo

Pricing:

Tiered

First dose:

Not disclosed

No arithmetic required, which is the whole point. Somira prints "$136.66 / month ($409.99 / quarter)" — the divided figure and the charge that will actually appear, in the same line. Month to month it is $189.99 for compounded semaglutide and $239.99 for tirzepatide, syringes and alcohol wipes included. The operationally useful detail: "No increase in price as you progress", so the number does not move when your dose does.

Semaglutide:

$189.99/mo on the monthly plan

Pricing:

Flat monthly, with a cheaper prepaid quarter

First dose:

Not published

Compounded semaglutide at $190 a month and tirzepatide at $275, the same price at every dose, medication and clinician access included — and then something no one else here does: the price drops the longer you stay consistent. Its own pricing page publishes the whole ladder, 10% off at a ten-day streak, 20% at twenty, 30% at thirty, which takes semaglutide down to $133 and tirzepatide to $192. Two things to weigh. The $190 and $275 are what you actually start on, so treat the low numbers as a discount you have to earn and keep. And nowhere on that page does it say what counts as a streak or what breaks one, which is the first thing worth asking.

Semaglutide:

$190/mo standard, before streak discounts

Pricing:

Flat, with a behavioral discount ladder

First dose:

Not published

Starting From $190/mo semaglutide and $239/mo tirzepatide, with two named compounding pharmacies and a genuine self-serve cancel-anytime policy — but no state list and no published time-to-first-dose figure. It also sells NAD+ injections ($219 one-time) and sermorelin ($149/mo) on the same account for anyone curious about broader longevity add-ons, and its FAQ confirms a video or phone consult is only required in certain states, not universally.

Semaglutide:

$190/mo

Pricing:

Flat

First dose:

Not stated

A general prescription menu with a GLP-1 line inside it — metformin from $25, testosterone therapy, sermorelin, NAD+ and glutathione beside the weight-loss plans. Compounded semaglutide is $190 a month and tirzepatide $239, both published before any intake, both flat as the dose titrates, and both with shipping included, which makes them easy to compare. The care is needed on the longer supplies. Clicking through returns $171, $426 and $1,092 against $190 for thirty days, and the site never states whether those are totals or per-month rates. Since $171 sits below the 30-day price it cannot be a ninety-day total, so rather than guess only the 30-day figures are treated here as prices. Beyond that the gaps are ordinary: pharmacies described as accredited and never named, no state list, and no time to first dose. Disputes run under Georgia law with arbitration in San Diego.

Semaglutide:

$190/mo

Pricing:

Flat as the dose titrates; longer supplies quoted on an unstated basis

First dose:

Not published

The widest menu on this list, and a slip on its own page that is worth knowing about. Read live on 2026-08-26, Invyncible sells nine GLP-1 programs on one account: compounded semaglutide in five formulations from $192.50 a month, compounded tirzepatide in four from $210, an oral semaglutide capsule at $255.50 for readers who would rather not inject, and FDA-approved Wegovy and Zepbound at $1,750 and $1,540. That flexibility is genuine — you can start compounded and move to a brand-name pen without changing provider. Two things to hold in view. Every figure is displayed as a permanent sale against a higher reference price, and both program pages say "Looking for a discount? Chat, Email or Call us!", so the listed number is an opening position rather than a rate. And its Wegovy card describes the product as "the FDA-approved brand-name tirzepatide treatment" — Wegovy is semaglutide. It names its parent company, Nationwide Telemedicine, LLC, and a street address, but not the states it serves.

Semaglutide:

$192.50/mo

Pricing:

Tiered

First dose:

Not disclosed

The widest menu on the board — compounded, oral and four brand pens, all on a chat visit with no camera — sold behind a pricing page that quotes you a monthly figure for a plan you have to pay for a year in advance.

Semaglutide:

$195/mo

Pricing:

Flat by dose; cheaper tiers prepaid

First dose:

About a week (site conflicts)

One flat $195/mo plan covers compounded semaglutide, compounded tirzepatide, or a needle-free sublingual option — plus real brand-name access if you want an FDA-approved pen instead — with a women's-health-first framing and a $99 first month, though it won't name your state until you're inside the signup flow.

Semaglutide:

$195/mo

Pricing:

Flat

First dose:

After provider review (timeline not disclosed)

Cost this at the dose you will end up on, not the one you start at. Tirzepatide runs $280 per four weeks at 2.5 mg and $525 at 15 mg — thirteen cycles a year, so $3,640 against $6,825. Semaglutide is stranger: two of its five levels cover five weeks rather than four, which makes level three cheaper per week than level two despite the higher dose, and contradicts the sentence directly above the table.

Semaglutide:

$195 per 4 weeks at the lowest dose, rising to $310

Pricing:

Scales with dose

First dose:

After a video visit with the practice

The arithmetic to do before you start: $196 a month is $588 on the first charge. Immortals — Bryan Johnson's longevity company — bills quarterly with three months paid up front, and it says so in a footnote on the same card as the price. What you get for it is a catalog with a figure on every item: compounded semaglutide $167 microdose or $196 personalized, tirzepatide $180 or $255, and brand-name alongside at $600 for Zepbound, $1,550 for Wegovy, $750 for Foundayo.

Semaglutide:

$196/mo for the personalized dose, billed quarterly

Pricing:

Quarterly billing, three months paid up front

First dose:

2 to 5 business days after prescribing

Starting prices of $197/mo semaglutide and $297/mo tirzepatide, compounded in the USA with no hidden fees stated directly and no video visit mentioned — pricing had to be pulled from the site's own compiled app data since it never showed up on a plain page load. Re-checked live on 2026-08-26, both tiles still read the same, and two things worth having are stated in its own footer: "Medication + Access to Coach & Doctors For The Same Price", and "Delivery in Just 48 Hours". Its FAQ is candid that the tile price is only a starting point — "Program pricing depends on the selected plan and medication. Full pricing details are shown during checkout" — so the maintenance-dose figure is not knowable until you have done the work. It publishes no state list, though it does give two addresses: a pharmacy in Springville, Utah and a medical provider in Des Moines, Iowa. And the same grid sells NAD+, sermorelin, B12-MIC, naltrexone, enclomiphene and a $399 DNA panel, several of them priced below the GLP-1 lines.

Semaglutide:

From $197/mo

Pricing:

Not disclosed

First dose:

Not stated

First, the confusion: this is not Nova MD. Different operator, different owners, and Nova MD is the one carrying an FDA warning letter naming its own domain — this company carries none. Nova sells a required $99 monthly membership plus medication, quoted all-in at $169 a month for a daily semaglutide oral dose, $174 for the daily tirzepatide oral dose, $198 for the weekly semaglutide injection and $210 for the weekly tirzepatide injection. A daily oral route beside the weekly shot is genuinely useful, and coverage has just widened to forty-nine states with California still to come. Then the pricing stops agreeing with itself. The semaglutide page leads with $198 above an FAQ headed "What does the $229/mo include?", and the tirzepatide page repeats it with $210 above one headed "$279/mo". Two further products, the needle-free weekly tablets, are advertised in the navigation while both pages load almost empty with no price at all. And the pricing page promises you are charged only if a provider prescribes, while the refund policy says the fees are not refundable even when you are declined.

Semaglutide:

$198/mo all-in

Pricing:

Required membership plus medication; the all-in figure varies by dose

First dose:

Not published

Compounded semaglutide at $199 a month and tirzepatide at $299, the same price at every dose, and the daily tablet costs the same as the injection on both — all of it on an open pricing page you reach without a quiz. Brand-name prices are published too, which is rare: Wegovy $999, Ozempic $899, Mounjaro $999, cash. Two things to know before you enter a card. The badge at the top of every page says no subscription, and its own FAQ then asks whether you can cancel your subscription and tells you to call before your next billing date — so it does recur, whatever the badge says. And nothing anywhere on the site says how many weeks of medication one $199 charge actually buys. It ships to all 50 states, and it carries a June 2026 FDA warning letter for false or misleading claims, which it has since fixed.

Semaglutide:

$199/mo, same price at every dose

Pricing:

Flat

First dose:

Days

The complete ladder is on the page before any intake, which almost nothing else here does: semaglutide $199 a month, $549 for three months, $999 for six, $1,788 for twelve; tirzepatide $299, $797, $1,494, $2,748. Read the long tiers correctly — each is a single upfront charge rather than a smaller monthly bill, so the advertised $149 means paying a full year before the first box ships. Disclosure is above average where it counts. Andrew Meds LLC is named with a Houston address, and the practice that writes the prescription is named separately as Dr Tel X in Kennewick, Washington. Coverage is all fifty states and DC, enumerated rather than claimed, and there is an oral tirzepatide alongside the injections. The gaps: the compounding pharmacy is never named, no time to first dose is published, and a period you have partly used is not refunded.

Semaglutide:

$199/mo

Pricing:

Flat by dose; four prepay tiers, each a single upfront charge

First dose:

Not published

The homepage and the pricing page tell different stories, and the pricing page is the kinder one. Every figure on the homepage carries the words "with annual prepay" — semaglutide starting at $169 a month, tirzepatide at $214 — which reads as though a year up front is the only way in. Open the full pricing table and each program has four tiers, the first labeled "Monthly · No commitment": semaglutide is $199 a month with nothing prepaid, tirzepatide $249. The prepay tiers are real savings rather than a gate — $2,028 buys a year of semaglutide at an effective $169. Everything is inside the figure: clinician evaluation, prescription, medication and shipping, with no separate consult fee. Nothing is charged unless a clinician prescribes; the card is authorized at intake as a hold, and if you are not prescribed you pay nothing. Review is typically within five hours and shipping three to five days. Coverage is 48 states plus DC, with Alaska and Mississippi named as the exclusions.

Semaglutide:

$199/mo month-to-month

Pricing:

Four tiers per program, from month-to-month down to annual prepay

First dose:

Clinician review in ~5 hours, shipping in 3–5 days

$199/mo semaglutide, $299/mo tirzepatide, three named co-founders, no contracts, a claimed ~24-hour NP review, and no live video visit described anywhere in the flow — undercut by an on-site 'FDA Approved' badge that overstates what's actually true about compounded GLP-1s, plus no pharmacy named and no state list disclosed. That combination — real speed and a named founding team, next to an overstated regulatory badge and thin disclosure elsewhere — is why Spry lands in the middle of the pack rather than near the top on this site's Rx-Readiness scorecard.

Semaglutide:

$199/mo

Pricing:

Flat

First dose:

~24 hours (NP review, per Spry's own claim)

Compounded semaglutide at $199 a month to month, the same price at every dose, with medication, clinician support and two-day shipping in the one price and no membership fee. The $139.99 the site advertises everywhere is not that rate: its own product page shows it is the three-month plan, and first-time-patient pricing on top of that. A returning patient on a monthly plan pays $199. Tirzepatide starts at $199 but its month-to-month rate is not published anywhere. Worth knowing too that the same figure appears three different ways across the site — $139.99, $140 and $139 — and that the $249 and $469 shown beside them are struck-through anchors rather than prices it charges.

Semaglutide:

$199/mo month-to-month, same price at every dose

Pricing:

Flat by dose; cheaper on a 3-month plan

First dose:

Not published

Two claims, one screen: a table reading "Intro rate (first quarter) $139/mo · Standard rate $199/mo", and immediately beneath it "The price you start with is the price you keep." Only one of those can be true. The bullets underneath imply the lock is about dose rather than the intro rate, but that is a reading, not a statement. Everything else is unusually well run: flat pricing at every dose, 47 states with the three exclusions named up front, a named 503A pharmacy, and physician review inside 24 to 48 hours.

Semaglutide:

$199/mo standard rate, not broken out by drug

Pricing:

Intro rate then a standard rate the site also calls locked

First dose:

Physician review within 24 to 48 hours, then shipping

Compounded semaglutide at $199/mo and tirzepatide at $299/mo once the first-month promo ends, from a named legal entity (NiceRx LLC, Boca Raton FL) with a checkable LegitScript badge — a transparent flat-rate program that never states how fast a first dose actually ships.

Semaglutide:

$199/mo

Pricing:

Flat

First dose:

Not disclosed

LegitScript-certified compounded semaglutide and tirzepatide, held flat at every dose — read live on 2026-08-26 the product pages still show "Starting at $199 $99 /month" and "$299 $183 /month", the higher figure struck through, exactly as they did three weeks earlier and still with no expiry on either discount. That is why this record ranks on $199 and $299: a discount with no stated end is a number you cannot plan against. The price genuinely includes the consultation, free cold-pack overnight shipping and every injection supply, and the flat-across-doses promise is stated in the first line of both pages. RxION is also more forthcoming than most about its own limits — it excludes New Jersey, Alaska and Mississippi in a footnote under the price, says that some states require a brief video consultation before a prescription can be issued, and states outright that it is not a pharmacy and that buying a program does not guarantee approval. What it does not publish is a physical address, the name of the pharmacy that fills your prescription, or how long any of it takes.

Semaglutide:

$199/mo

Pricing:

Flat

First dose:

Not disclosed

A small, physician-led practice — Dr. Tran Le personally, capped at ~500 patients — $199/mo semaglutide, $249/mo tirzepatide, all-inclusive, but limited to Texas and Utah only.

Semaglutide:

$199/mo, all-inclusive

Pricing:

Flat

First dose:

Not published

A broader wellness platform (GLP-1s plus NAD+, sermorelin, HRT, hair growth) offering both compounded ($199/mo semaglutide, $299/mo tirzepatide) and brand-name Ozempic/Zepbound access — though the site shows three different, unreconciled price claims across its own pages, so confirm the real number at signup. The three are the $199/mo standing tier, a $169/mo three-month prepay plan badged 'Best Value', and a countdown-timer banner advertising 'as low as $119/mo' that matches neither. Brand-name access is listed only as 'also available', with no price shown on any page we checked, so the compounded tiers are the only figures you can plan around.

Semaglutide:

$199/mo standard

Pricing:

Tiered

First dose:

Not published

A menopause clinic that treats GLP-1 weight care as a menopause problem, which almost nothing else on this roster does. Four routes are published with prices attached: semaglutide injection at $199 a month, semaglutide dissolving tablets at $279, tirzepatide injection at $249 and tirzepatide sublingual drops at $229, flat at every dose, with anti-nausea support included free for the first two months. The catch is a real one and it is not hidden in the small print so much as split across two pages. The weight page promises no membership and one all-in price; the Terms you actually agree to describe membership plans, recurring charges, and medication billed separately on top. Get which one applies to you in writing before you subscribe.

Semaglutide:

$199/mo injection ($279/mo oral tablet)

Pricing:

Flat

First dose:

Not disclosed

Compounded semaglutide at a standard $199 a month and tirzepatide at $299, medication included, with a genuine microdose line underneath at $79. The promotional rates it leads with are $119 and $219. Two things worth knowing before you compare it with anything else here. It serves 26 states rather than all 50, and it does not publish which. And the '$49/mo' on most of its medication cards is a membership fee with the medication paid separately — that lane covers Wegovy, Ozempic, Zepbound and Mounjaro, and the drug cost is never shown. It carries a February 2026 FDA warning letter, cited partly for putting its own name on the pictured vial, which it has since fixed. What it does better than most: a registered dietitian is included for every patient.

Semaglutide:

$199/mo standard, medication included

Pricing:

Flat

First dose:

Not published

Built for women, and priced one tier below what it charges. The banner offers "GLP-1 weight care for women from $149/mo" and no program costs $149; the tirzepatide card says from $199, which is really the semaglutide rate. Alinwell's own program catalog reads $199 semaglutide, $249 microdose, $349 tirzepatide — so budget $349 for the dual agonist, $150 above the card. The microdose track, the usual route to a smaller bill, is $50 a month more than standard semaglutide. On the credit side it names its operating company plainly, Alinwell LLC, and holds the rate flat once you are on a program. Two pieces of social proof, a 4.8 Trustpilot score and a 4.9 Google rating, could not be matched to any profile. No state list, no compounding pharmacy, and no stated time to first dose.

Semaglutide:

$199/mo

Pricing:

Flat per program — but every advertised rate is one tier below the real one

First dose:

Not published

The spread here is the largest on the page and it is honestly stated: $2,388 a year paying monthly against $1,188 on the twelve-month plan, a difference of $1,200. Every division checks out to the dollar, and semaglutide and tirzepatide cost the same. The one thing that does not fit is the headline on that same page — "as low as $249.97/Month" — which is higher than every plan the selector offers.

Semaglutide:

$199/mo month to month

Pricing:

Tiered

First dose:

Days after the online consultation

Cost a year out and the plans make sense: $1,548 for twelve months of semaglutide against $2,358 paying month to month, so committing saves $810. What does not make sense is that three pages of this site quote three different prices for the same treatment, the highest being a $550 a month that nothing in the plans reaches. The plan totals themselves are exact — all six of them. The tablet plans, however, tell you that what arrives is tirzepatide.

Semaglutide:

$199/mo

Pricing:

Tiered

First dose:

Days — free consult, then shipped to your door

A genuinely strong 90-day money-back guarantee and free 2-4 day shipping at a flat $199/mo ongoing rate covering either molecule (starting at $149 the first month, or $165/mo on a 3-month plan) — undercut by no disclosed state list and no separate semaglutide/tirzepatide pricing.

Semaglutide:

$199/mo

Pricing:

Tiered

First dose:

Not disclosed

The two prices on Oria's front page are not purchasable. It advertises a compounded GLP-1 from $149 a month and a dual GLP-1 and GIP from $249, and neither figure appears anywhere on the plan menu at checkout, where the real rates are $199 for semaglutide with B12 and $369 for tirzepatide with B12, both flat across dose levels with shipping included. A second oddity matters before committing: on semaglutide the three- and six-month plans are $209 a month, more than the $199 payable month to month, and they ship every three months — so committing longer costs more and delivers less often. Against that sits something genuinely good. Oria names its dispensing pharmacy outright, PerfectRx of Flower Mound, Texas, which most compounded sellers never do. It also never names the molecule anywhere on its public site, so you learn which drug you are buying only at the second step of the intake. No state list and no time to first dose are published.

Semaglutide:

$199/mo

Pricing:

Flat across doses, but the public figures are not the plan-menu figures

First dose:

Not published

$199/mo ongoing semaglutide (after a $99 six-week intro) and a $330 one-time 6-week tirzepatide supply, from a named prescriber (Dr. Steven Bunker) — genuinely current behind a stale 2023 footer copyright that's worth knowing about, not worrying about.

Semaglutide:

$199/mo

Pricing:

Tiered

First dose:

After provider review (timeline not disclosed)

A clearly labeled $199/mo semaglutide or $299/mo tirzepatide month-to-month, dropping to $89/$129 only with a 6-month prepay — through a named clinical network but no named pharmacy, no published cancellation policy, and no stated turnaround time. The prepay math is worth doing before you commit: six months at the discounted rate is still a real up-front commitment, not a free trial, so confirm the refund terms on that prepay before you send it.

Semaglutide:

$199/mo

Pricing:

Flat

First dose:

Not stated

A genuine oral option at $179–$199/mo undercutting its own $199–$299/mo injectable pricing, LegitScript Certified with NYC pharmacy locations opening — undercut by an unanswered 'what states do you ship to' FAQ and marketing phrasing that blurs FDA-registered-facility with FDA-approved-drug.

Semaglutide:

$199/mo

Pricing:

Tiered

First dose:

Not disclosed

LegitScript certified with FDA-registered-facility and 503A-pharmacy badges and a 6-month-plan discount to as low as $176/mo semaglutide — undercut by a genuine, disclosable self-contradiction on its own site over whether all 50 states or only 45 are actually served.

Semaglutide:

$199/mo

Pricing:

Tiered

First dose:

Not disclosed

A concierge medicine practice (in-person in LA, NY, and 25+ cities, plus mail order) with compounded semaglutide at $199/mo (90-day shipments) and tirzepatide at $299/mo (60-day shipments), each on a 4-month minimum — and, unusual for this list, real brand-name Ozempic and Wegovy at $1,999/mo.

Semaglutide:

$199/mo

Pricing:

Flat

First dose:

Not disclosed

Both molecules start 'as low as' $199/mo semaglutide and $259/mo tirzepatide, injectable or oral — but that's a floor, not a real price: no per-dose ladder, no state list, and no confirmed price for the consultation you're required to complete.

Semaglutide:

$199/mo

Pricing:

Not disclosed

First dose:

After a required online consultation (timeline not disclosed)

Only one figure here supports a budget. Tirzepatide is $199 a month, stated as including the consultation, the medication, supplies and shipping — that is a number you can multiply by twelve. Semaglutide is $99 for "your first 4 weeks" with nothing published for week five onward, so there is no annual figure to compute. And the section headed "Transparent Pricing" on the semaglutide page prices low-dose naltrexone, methylene blue and testosterone — not semaglutide.

Semaglutide:

$99 for the first four weeks; ongoing rate not published

Pricing:

Not disclosed

First dose:

After a free provider consultation

Standing monthly rates of $199 for compounded semaglutide and $299 for compounded tirzepatide, each fronted by a $99 first-month promotion that is the number the marketing actually leads with. Read live on 2026-08-21, the plan cards say it plainly — "Starting at $99 / 1st Month (Originally $199 / month)" — so the discount is real and it lasts exactly one month. Two things sit alongside it that a reader should see. Quarterly plans are also offered at $297 and $449 and are labeled per month on the card, which cannot be reconciled against the cheaper monthly plans from the public page alone, so those figures are not asserted here. And the page was running a Cyber Week banner with a fifty-percent-off countdown reading zero hours, zero minutes and zero seconds — in August. Against that, its disclosure is better than most: three operating entities are named, including the prescribing practices Beluga Health, P.A. and Pennsylvania Medical, P.C., and all three screened clean against the full live FDA warning-letter index.

Semaglutide:

$199/mo

Pricing:

Promotional first month, then a standing rate

First dose:

Not published

There is one number to work with — "Plans from $199/mo · confirmed after provider review" — and it is not a commitment, it is a starting point subject to an intake you have not done yet. The stat block beside it reads "0 states telehealth access", an unfilled counter still live. The claim that deserves the most scrutiny is the headline: "~15–20% avg. body-weight change", attributed to "multi-center, placebo-controlled national clinical trials of Compounded Semaglutide and Tirzepatide formulations". No such trials exist. Those figures come from studies of the branded drugs.

Semaglutide:

From $199/mo, not confirmed until after provider review

Pricing:

A single "from" price, confirmed only after provider review

First dose:

Not published

A concierge medical weight-loss and hormone clinic with lab-guided dosing and a named PA-C (Mathew Hammons) leading care — compounded semaglutide from $200/mo and tirzepatide from $250/mo, in just five telehealth states plus one in-person Joplin, MO clinic, LegitScript certified with HSA/FSA receipts provided, though its own homepage overstates the medication's FDA status by calling compounded product 'FDA-approved.'

Semaglutide:

$200/mo (compounded, from)

Pricing:

Scales with dose

First dose:

Not published

The best-documented supply chain on this board — seven pharmacies with addresses and phone numbers — attached to a shop that will not show you a single price until you have started a medical intake.

Semaglutide:

$205/mo (quiz-gated)

Pricing:

Flat by dose; no public price

First dose:

24h review; transit not published

The Edit is one of the very few providers on this page that names both the medical practice writing your prescription and the pharmacy compounding it — Arora Health & Aesthetics, LLC and The Pharmacy Hub — rather than gesturing at 'licensed US providers'. Compounded semaglutide is $209 a month and tirzepatide $309, the same price at every dose, with the prescription, all injection supplies, the clinician visit and temperature-controlled two-day shipping inside that one number and no membership fee on top. First orders are $100 off, and three- and six-month plans bring the per-month equivalent down to $192 and $178 for semaglutide. It covers all 50 states and, unusually for this market, runs a complete Spanish-language version of the site rather than a machine-translated shim. The limits are real but narrow: it is compounded-only, so there is no FDA-approved Wegovy or Zepbound here, and there is no postpartum, breastfeeding or PCOS guidance anywhere on the site.

Semaglutide:

$209/mo

Pricing:

Flat

First dose:

Clinician review, no published turnaround

Convert before comparing: "Starting at $49/week" is about $212 a month, and the page never does that arithmetic. The claim worth pausing on is "20% Avg body weight lost", positioned in the statistics strip beside "10K+ Active members" as though it were a measured cohort average. Roughly 20% is tirzepatide's result at its top dose in a controlled trial; no telehealth service has published anything comparable.

Semaglutide:

$212/mo, billed as $49/week

Pricing:

Billed weekly

First dose:

Delivered in 3 days or less, per the site

The annual decision here is unusually large and clearly stated. Semaglutide is $2,579.40 paying monthly against $1,684.95 on the twelve-month plan — a gap of $894. Tirzepatide is $3,119.40 against $2,044.95, a gap of $1,074. The advertised "$140/mo" is the annual tier, and the asterisk says so. It also holds your card rather than charging it, and only bills once a doctor has prescribed.

Semaglutide:

$214.95/mo month to month

Pricing:

Tiered

First dose:

After a doctor reviews; the card is only charged then

A five-state compounded option — AZ, CA, FL, NV, TX only — priced well above the roster median at $215/mo semaglutide and $320/mo tirzepatide, with no stated time-to-first-dose. Its own copy states plainly that these are compounded, not FDA-approved, medications, and requires a telehealth Good Faith Exam before any prescription is issued.

Semaglutide:

$215/mo

Pricing:

Flat

First dose:

Not disclosed

A tirzepatide-only (no semaglutide) provider with an all-inclusive, 4-week-cycle dose ladder starting at $224 and now offering a needle-free oral dissolvable tablet option — cash-pay, with no state list or named pharmacy published.

Semaglutide:

Not offered

Pricing:

Tiered

First dose:

Not published

Work the total and you get $224 a month, not the $199 on the vial and definitely not the $129 on the homepage. The membership is $25 and it is compulsory to buy. The vial covers four weeks, so budget thirteen of them across a year rather than twelve — call it $2,912 for a first year of semaglutide. What you get for that is a price that does not move as you titrate and nothing that renews unless you press the button.

Semaglutide:

$224/mo all-in

Pricing:

Flat

First dose:

Days — provider review, then cold-packed shipping

Now Try Invigor after a domain rebrand from Invigor Medical, pricing two mechanism-based tiers — $225 a month and $350 — via a phone consultation rather than a scheduled video visit, and still never naming the actual molecule on any page. Read live on 2026-08-26, both figures are unchanged since early August. What has changed is what we could find out: its plan pages, which this record had not previously opened, answer the compounded question outright — "Try Invigor does not supply FDA-approved branded medications", everything is compounded by licensed 503A pharmacies, with third-party lot testing including a sterility check published beside it. They also do something almost nothing else on this roster does, which is address pregnancy directly: GLP-1 medications may harm a fetus, should not be used when planning to conceive, and should be stopped at least two months before a planned pregnancy. For a reader on a site like this one, that sentence is worth more than the price.

Semaglutide:

From $225/mo

Pricing:

Not disclosed

First dose:

Not stated

A genuine 12/6/3/1-month commitment ladder running $95–$225/mo semaglutide and $145–$265/mo tirzepatide, all 50 states + DC, no membership fee — the cheapest numbers require locking in a full year up front.

Semaglutide:

$225/mo

Pricing:

Tiered

First dose:

Free initial visit, billed only on approval (shipping timeline not disclosed)

Compounded semaglutide at $225/mo and tirzepatide at $299/mo, shipped everywhere except Alabama — but the FDA issued Lyfe Rx its own FDA warning letter on 09/09/2025 for false or misleading claims about these exact products, confirmed directly on FDA.gov and never mentioned by the site itself.

Semaglutide:

$225/mo

Pricing:

Flat

First dose:

Not disclosed

Two different businesses are described on one site, and which one you get decides the cost entirely. The homepage sells a flat $225 a month with medication included. The FAQ says it accepts most major insurance, that your prescription cost depends on your plan, and explains how to fax your details in. A flat fee and a copay are not the same budget, and nothing on the site says which applies.

Semaglutide:

From $225/mo including medication, plus a $50 consultation

Pricing:

Not disclosed

First dose:

After a $50 consultation

Two structural problems sit above the price. Goldspan publishes no figure anywhere on its own website — not on the homepage, not on the weight-loss category page — and every product links out to a separate storefront on another domain, where semaglutide finally reads $229 and tirzepatide $299, each with B12. That storefront then advertises the price as monthly while stating a new supply arrives automatically every four weeks, which makes a year thirteen charges rather than twelve: about $2,977 for semaglutide and $3,887 for tirzepatide, roughly $230 and $300 above what a monthly reading implies. Both were already at the higher end before that adjustment. What is genuinely solid: eleven protocol categories on a longevity platform, dispensing through licensed 503A and 503B pharmacies, and a flat price at any dose. The homepage's fifty-state claim is qualified by its own terms, and no time to first dose is published.

Semaglutide:

$229 per 4 weeks

Pricing:

Flat at any dose, billed every 4 weeks rather than monthly

First dose:

Not published

One of the most transparently priced compounded shops in this batch — $230/mo semaglutide or $330/mo tirzepatide month-to-month, down to $120/mo and $170/mo on the annual plan, with an explicit no-membership-fee guarantee.

Semaglutide:

$230/mo standard, $120/mo on the annual plan

Pricing:

Tiered by plan length

First dose:

Not published

A real, named 27-state list instead of a vague nationwide claim — $247/mo semaglutide, $296-396/mo tirzepatide depending on dose tier — but no stated time-to-first-dose, and its FAQ and Terms pages both 404'd.

Semaglutide:

$247/mo

Pricing:

Tiered

First dose:

Not disclosed

The habit-plus-medication route: Noom bolts a prescriber onto its behavior-change app, runs mostly async, and will chase brand-name coverage through insurance — but it won't tell you which molecule you're getting or your true quarterly total up front.

Semaglutide:

$249–299/mo (molecule not itemized; $199 microdose tier)

Pricing:

Tiered

First dose:

About a week

A flat $249/mo semaglutide, $339/mo tirzepatide, or $279/mo oral tablet — one all-inclusive price with no separate consult fee — though its earlier page-to-page price conflict on semaglutide is a reminder to check the exact page you're quoted on before you pay.

Semaglutide:

$249/mo

Pricing:

Flat

First dose:

After provider review (timeline not disclosed)

Every price is public and the company is not. Six figures sit on the product pages before any intake: semaglutide $249 a month, $649 for three months, $1,199 for six; tirzepatide $349, $949, $1,799 — about $200 and $300 a month at the longest term. Each advertised saving is exact against its own monthly rate, which is more than most manage. The problem is in the legal pages. No operating entity is named anywhere on the site, and the terms and privacy policy are an unfinished template: the compounding pharmacies, the laboratories and the medical groups are all bracketed placeholders, and so is the site's own web address. Nothing states how long the first dose takes. It also sells NAD+, sermorelin and glutathione, claims all fifty states without listing them, and says nothing about pregnancy, breastfeeding or postpartum timing.

Semaglutide:

$249/mo

Pricing:

Tiered by supply length; the per-month rate falls with the term

First dose:

Not published

A flat, all-inclusive price for semaglutide, tirzepatide, or a needle-free oral option — but no stated time-to-first-dose and no clarity on whether intake requires a scheduled video visit, both real gaps for a working parent planning around a calendar.

Semaglutide:

$249/mo

Pricing:

Flat

First dose:

Not disclosed

$249 semaglutide, $349 tirzepatide, month to month, flat at every dose. Those are the only recurring rates. The cheaper tiers are prepayment — '$159/mo' is $477 once, three months shipped together, select states only. Brand Wegovy and Zepbound available as a $99 care fee, drug billed separately. FDA letter 717991 from February 2026, still open; the cited claims have been removed from the site.

Semaglutide:

$249/mo month-to-month

Pricing:

Flat by dose; cheaper tiers prepaid

First dose:

Not published

Both molecules priced identically under the same tiered structure — $249/mo standard, dropping to $199/mo on a 3-month plan or $165/mo on a 6-month plan — nationwide, with a $179 first-month promotional rate.

Semaglutide:

$249/mo standard

Pricing:

Tiered

First dose:

Not published

A flat-fee solo-provider program — $249/mo semaglutide, $379/mo tirzepatide, Quest labs included, with an explicit 'no increases as you continue' promise — but coverage is limited to 20 named states.

Semaglutide:

$249/mo, flat

Pricing:

Flat

First dose:

Not published

Compounded semaglutide at $249 a month and tirzepatide at $297, held flat across every dose from the starting 0.25 mg all the way to the top of the ladder — and, unusually, priced identically whether you take it as an injection or an oral. TMates publishes its full commitment ladder up front rather than revealing it at checkout: three, six and twelve-month terms at $217, $175 and $158 a month for semaglutide and $267, $217 and $167 for tirzepatide, each shown with the total you actually pay. Every advertised saving checks out against the month-to-month rate. What it does not publish anywhere is the list of states it serves, so you cannot confirm availability before starting.

Semaglutide:

$249/mo

Pricing:

Flat

First dose:

Not published

Rare for showing compounded AND brand-name pricing on the same page, with one of the faster named review windows (24 hours) checked this round — semaglutide from $149/mo, tirzepatide from $249/mo on 3-month plans — but its own FAQ quotes a stale price the live checkout has already undercut.

Semaglutide:

$249/mo month-to-month ($149/mo on the 3-month plan)

Pricing:

Tiered

First dose:

A few days after approval

The arithmetic to do before you sign up: $117 a month is $1,404 charged today. Every advertised figure on this site — $117, $150, $198, $240 — carries the line "Paid annually, delivered monthly". The pay-as-you-go numbers are on the same page, to Fridays' credit: $249 for compounded semaglutide, $359 for tirzepatide. Worth a second look before you decide: the "96.8% success rate" printed next to before-and-after photos is footnoted as a measure of whether packages shipped on time.

Semaglutide:

$249/mo on the month-to-month plan

Pricing:

Prepaid annual by default; month-to-month costs more

First dose:

Not published

A real dose-tier ladder — $249–$349/mo semaglutide, $349–$649/mo tirzepatide-plus-B12 — through named pharmacy partner Strive Pharmacy, undercut by an 'all sales are final' cancellation policy and no published state list.

Semaglutide:

$249/mo

Pricing:

Tiered

First dose:

Not disclosed (medication ships to your door once approved)

The arithmetic only works if you notice the unit changed. $199 does not buy a month here — it buys a vial capped at 1 mg, and $299 buys one capped at 2.5 mg, with a $45 one-time appointment fee and $19 shipping added on top. Run against the subscription column instead and the real monthly figures are $249 for semaglutide and $349 for tirzepatide, provider and shipping included. Two products, two units, one page.

Semaglutide:

$249/mo on the subscription plan

Pricing:

Dose-capped vials, or a separate monthly subscription

First dose:

Not published

The Q&A brand's weight-loss arm sells "Semaglutide + B12" and "Tirzepatide + B12" on four prepay tiers we had to pull from its JS bundle — the real no-prepay rate is $249.97/mo and $349.97/mo, not the 12-month rate its own ad pixels quietly treat as the price.

Semaglutide:

$249.97/mo

Pricing:

Tiered

First dose:

Not disclosed

Costed plainly: $250 a month for semaglutide, $325 for tirzepatide, $149 for the oral version, from a clinic with an address in Oakland, Maine and free Wednesday consultations. Then there is a $100 line item that should stop the calculation — "Add Retatrutide to your current Semaglutide or Tirzepatide regimen." Retatrutide has no FDA approval for any indication and is still in phase 3. There is no labeled dose to budget for and no safety data to weigh.

Semaglutide:

$250/mo

Pricing:

Tiered

First dose:

In person; free consults Wednesday afternoons

AurenRx names both the practice that prescribes and the pharmacy that compounds, with addresses — Wasef Health, PC c/o Michael Wasef MD in Pinellas Park, Florida, and VialsRX in Houston, Texas — and the prescriber's details match the federal NPI registry exactly. It charges the same for either molecule, which is genuinely unusual: $259 a month on a recurring plan or $299 with no commitment, for semaglutide or tirzepatide alike, plus a low-and-slow microdose track at $229/$250. Everything is included in that price, the online visit is free, and the LegitScript badge it displays is real. The problem is its own front page. AurenRx advertises its GLP-1 and Microdose programs at 'from $129/mo' on the homepage, while the cheapest thing you can actually buy on the product page is $229 — nothing costs $129. That is not a promotion that expired or a plan you have to hunt for; it is roughly half the real price, sitting on the page most readers see first.

Semaglutide:

$259/mo

Pricing:

Flat

First dose:

Free online visit

It names four dispensing pharmacies outright and identifies who prescribes, which almost nothing else here does, and charges the same whichever molecule you pick — $259 a month on the full-dose program, $219 on maintenance and microdosing, semaglutide or tirzepatide, oral or injectable. For the dual agonist that is worth real money, since most sellers add $80 to $150 a month. The pricing you meet first is the problem: the homepage advertises programs starting at $199 and $159, nothing is priced at either, and the asterisks beside both lead to no footnote anywhere on the page. The cheaper rates it does publish are prepaid terms rather than monthly bills — $186 a month means 52 weeks, $200 means twelve. Canceling needs 72 hours' notice before the next billing date or that cycle is charged, and no refund is issued for the month you cancel or any before it. No time to first dose is published.

Semaglutide:

$259/mo

Pricing:

Flat per program, same price either molecule; cheaper rates need a prepaid term

First dose:

Not published

Priced by how long you commit rather than how much you take: compounded semaglutide is $269 a month without a commitment and $199 on a 48-week plan, with tirzepatide at $369 and $299, and the 12- and 24-week plans between at $249 and $229 for semaglutide. The advertised "from $199 per month" is the year-long option, so the honest uncommitted figure is about 35% higher, and the longer plans ship every twelve weeks. Because price is set by commitment rather than dose, the bill does not climb as you titrate — a real advantage if you are budgeting ahead. Two things deserve attention first. The product pages never name the molecule at all, selling only a "GLP-1" and a "GLP-1 + GIP", with semaglutide and tirzepatide appearing nowhere except the terms. And the same three testimonials run on both product pages, one about the dual agonist while sitting on the semaglutide page, beneath a "Loved by 800+ women" line carrying no source. No time to first dose is published.

Semaglutide:

$269/mo

Pricing:

Tiered by commitment length, not by dose

First dose:

Not published

The decision here is binary and it is worth making before you look at the price. Twelve months of injectable semaglutide costs $2,148 up front, which is $179 a month. Paying monthly costs $269, so a year that way is $3,228 — a difference of $1,080. That figure is on the page, and when recomputed it is exactly right, as are the other seven. This is a Spanish-language practice, and the front page shows only the annual column.

Semaglutide:

$269/mo month to month

Pricing:

Tiered

First dose:

Days after the medical evaluation

Joey Med publishes real prices on its product pages without an intake wall — a rarity — but a working mom scanning quickly will see the bold $199/$275 first-fill number, not the higher $279/$399 standing rate printed smaller on the same page.

Semaglutide:

$279/mo

Pricing:

Tiered

First dose:

Not disclosed

The telehealth weight-management arm of WellNow Urgent Care — a flat $279/mo covers compounded semaglutide, supplies and unlimited virtual visits with no hidden fees, standard 18-plus/BMI-30 (or 27-with-comorbidity) eligibility, and the site honestly discloses the medication isn't FDA-approved, but it's semaglutide-only in just five states (IL, IN, MI, NY, PA) with no insurance accepted.

Semaglutide:

$279/mo all-inclusive

Pricing:

Flat

First dose:

Not published

Budget from $279, not $139. Ozi's own line reads "$139 for your first 4 weeks, then $279/mo", while a badge above the same offer calls it "first month 50% off" — so the introductory window is given in weeks in one place and months in another, and it roughly doubles either way. Tirzepatide is the same shape at $189 then $379. Longer commitments genuinely cut the rate, 22% at twelve weeks up to 47% at fifty-two, but they are billed once up front and ship every four weeks, so the discount is bought with flexibility.

Semaglutide:

$279/mo after the introductory period

Pricing:

Flat; introductory period measured in weeks

First dose:

Not published

No video visit, 5-7 business days to ship, and a full pricing dropdown you can see before you buy — $295/mo flat for semaglutide, $295-$595/mo for tirzepatide by dose.

Semaglutide:

$295/mo flat (any dose)

Pricing:

Scales with dose

First dose:

5-7 business days after approval

Three clearly-labeled commitment tiers — from $150/mo prepaid annually up to $297/mo month-to-month for semaglutide — with the standing no-commitment rate the number to actually budget against, not the homepage's annual anchor.

Semaglutide:

$297/mo

Pricing:

Tiered

First dose:

Not disclosed

Henry advertises that GLP-1 medication starts at $179 a month, and that is true of something other than the weekly semaglutide shot. Read live on 2026-08-26, its own itemized programs page shows $179 buying daily liraglutide injections or sublingual semaglutide drops; compounded semaglutide as a weekly or biweekly injection is $297 a month. Tirzepatide is not sold as an injection here at all — it appears only as an oral three-month package at $1,047, or $891 paid in full. What Henry does better than most of this roster is tell you exactly what is in the price: provider visits, medication and supplies, shipping and ongoing care are all included, with no insurance and, in its own words, no hidden or surprise fees. It also publishes a real turnaround, 8 to 10 business days after the provider visit, and warns that California takes longer because of additional compound testing. Two things to walk in knowing. A video visit is the default, with an independent review without one available only depending on your home state, and Henry does not say which states those are. And one row on its own programs page contradicts itself, describing orally dissolving tirzepatide tablets under a Semaglutide Oral heading.

Semaglutide:

$297/mo compounded injection

Pricing:

Flat per program, all-inclusive

First dose:

8 to 10 business days after the provider visit; longer in California

Compounded semaglutide at $299 and tirzepatide at $399, quoted as a monthly program but sold as a FOUR-WEEK supply — a distinction that costs you an extra cycle roughly every year and is easy to miss because the site itself writes it as per month. The price is reachable without finishing the quiz, but only inside a collapsed FAQ rather than on any pricing page. Prime Health is a platform rather than a practice: it states plainly that it does not provide medical services, with clinicians supplied through the OpenLoop professional corporations, and its own copy still refers in places to the Remedy Meds platform it is built on. It covers every state except Louisiana and backs the program with a stated money-back guarantee tied to losing at least 10% of body weight in four months.

Semaglutide:

$299 per 4-week supply

Pricing:

Flat

First dose:

Not published

The pelvic-floor brand that a lot of women already own a set of Kegel weights from, now selling compounded semaglutide at $299 a month and tirzepatide at $399, injection or oral at the same price either way. Billing is a genuine calendar month, which is rarer here than it sounds, and prepaying drops the rate to $183 a month on a year of semaglutide. Two things the landing page will not tell you. It advertises treatment 'as low as $169/MONTH' and that figure is not reachable anywhere in the catalog — the cheapest actual monthly rate is $299. And it carries an FDA warning letter from September 2025 about this drug line specifically, which it does not mention anywhere on its own site.

Semaglutide:

$299/mo

Pricing:

Flat

First dose:

Not disclosed

Two of the three things this record used to say were unknown are now answered, and the answers change the picture. Read live on 2026-08-26, Heally's own semaglutide page prices its program from $149 a month — and the same page says which form that buys: "the semaglutide pill (once daily, from $149 per month, no needles) or the semaglutide pen for injections", with no price given for the pen. It also says it serves all fifty states, with 250,000 patients treated. What has not changed is the tirzepatide line: "From $299/mo" still carries a NEW PATIENT OFFER badge directly above it and the renewal rate appears nowhere, so the only tirzepatide number you can see is the one that expires. The rest is unusually reader-friendly: no membership and no subscription ever, a free doctor consultation, pay only when you order, delay a refill any time, and delivery within 24 to 48 hours of approval. The trade is time — a 15-minute telehealth appointment is part of the path rather than optional. Heally is also a broad marketplace rather than a GLP-1 shop, with longevity protocols, hormone therapy and lab panels on the same menu.

Semaglutide:

From $149/mo for the oral pill

Pricing:

Pay per order, no membership; the tirzepatide figure is an introductory rate

First dose:

Same-day appointment, delivery in 24–48 hours after approval

A flat $299/mo semaglutide or $399/mo tirzepatide that never changes as your dose is titrated, bundling 24/7 coaching and community access — priced above most of this batch, and with no published state list.

Semaglutide:

$299/mo

Pricing:

Flat

First dose:

Not stated

FDA warning letter #714755 (Sept. 2025), which names mystarthealth.com. A flat $299/mo all-inclusive program — consults, medication, and shipping bundled at one price-locked rate for either molecule — advertising same-day physician consultations, from a Delaware LLC with a real disclosed address, undercut by no LegitScript certification confirmed and a strict no-refund-after-shipping policy.

Semaglutide:

$299/mo

Pricing:

Flat

First dose:

Same-day physician consultation, per its own homepage FAQ

Flat, all-inclusive compounded pricing plus a real path to FDA-approved Wegovy — but no stated turnaround time, and state coverage is only documented for a handful of states, both real planning gaps for a working parent.

Semaglutide:

$299/mo

Pricing:

Flat

First dose:

Not disclosed

Kova is the rare site where the arithmetic is already done and comes out right. "3-month plan: $179/month, or $537 upfront" — and $179 × 3 is $537 exactly, which holds for all eight of its plans. That matters because plenty of sellers advertise a per-month figure that is really an average with a one-off discount folded in; these are not. Month to month, the number to plan around is the renewal: $299 for semaglutide, $399 for tirzepatide, after a cheaper first month.

Semaglutide:

$299/mo after the first month on the one-month plan

Pricing:

Intro month then a renewal rate, or a discounted fixed term

First dose:

Not published

A flat, locked-in $299/mo for an oral semaglutide + B6 tablet from a publicly traded men's-health company (Mangoceuticals) — but its own weight-loss page is titled "Medical Weight Loss for Men" and never once mentions women, pregnancy, or breastfeeding.